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Abstract 
Previous work from our laboratory has demonstrated that estrogen will attenuate 
leukocyte infiltration into skeletal muscle following eccentric exercise. However the 
mechanisms by which estrogen exerts its effects are still uncertain. In experiment one, we 
investigated the role of estrogen receptor (ER) influence on muscle leukocyte infiltration 
following eccentric exercise through administration of the ER antagonist ICI 182,780 
following downhill running in ovariectomized female rats with (E+) or without (E-) 
estrogen supplementation. At 24 hours post-exercise, soleus and white vastus muscles 
were removed and immunostained for HIS48 (neutrophil) and EDI (macrophage) 
positive cells. The increase in number of fibres positive for HIS48 in soleus and positive 
for EDI in the soleus and white vastus was significantly attenuated (p<0.05) in En-
relative to E- rats at 24 hours post-exercise. E+ rats administered the ER agonist also had 
significantly (p<0.05) attenuated 24 h post-exercise increases in HIS48 and EDI positive 
soleus and white vastus muscle fibres similar (p>0.05) to those without ER antagonist. 
This suggests that the ability of estrogen to attenuate post-exercise leukocyte infiltration 
into skeletal muscle is not ER-mediated. 
In experiment two, we examined the interaction effects of estrogen and 
progesterone on skeletal muscle in response to injury in ovariectomized female rats. At 
24 hours post-exercise, soleus and white vastus muscles were removed and 
immunostained for HIS48 (neutrophil) and EDI (macrophage) positive cells. Leukocyte 
infiltration 24 hours post-exercise in the soleus (red) and white vastus muscles were 
significantly decreased in ovariectomized rats treated with progesterone alone relative to 
unsupplemented ovariectomized rats. Following exercise the percentage of leukocyte 
ii 
infiltration also decreased significantly with estrogen supplementation alone in both 
muscle types, 67-69% and 63-74% in neutrophils and macrophages, respectfully. 
Furthermore, the combination of estrogen and progesterone supplementation did not 
significantly alter the attenuation observed by estrogen alone. These results demonstrate 
that skeletal muscle in female rats benefited from both progesterone or estrogen treatment 
alone; effects of progesterone with estrogen following exercise were neither greater nor 
less than with estrogen alone. 
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Chapter One 
Introduction 
Skeletal muscle is a vital component of the body. Skeletal muscle is composed of muscle 
fibres that function together to perform contractions. The force generated through these 
contractions enables movement in the body. Skeletal muscle function can be impaired by 
trauma resulting from crush injury, lacerations, disuse and excessive exercise (1). 
1.1 Skeletal Muscle Injury 
Unaccustomed strenuous exercise, especially eccentric exercise can, cause muscle 
damage. Eccentric muscle contractions allow the muscle to develop force as it is being 
lengthened by an external load. McCully and Faulkner (2) investigated exercise-induced 
muscle injury proximal to the distal tendon of the extensor digitorum longus (EDL) 
muscle of anesthetized mice. The muscle was exposed to bouts of eccentric, concentric 
or isometric contractions, for which the muscle length, muscle velocity, level of muscle 
activation and the number of contractions were controlled. Following the contraction 
protocols the distal tendon was reattached and the animals were allowed to recover. 
Three days post-exercise, eccentric contractions in the muscle showed histological signs 
of damage and a reduction in maximum isometric muscle force. Exercise protocols of 
equivalent intensities involving isometric and concentric contractions did not result in as 
much muscle injury as those observed with the eccentric contractions (2). Eccentric 
exercise causes more damage than concentric exercise. This is thought to be because 
fewer motor units are recruited during eccentric exercise, resulting in a smaller cross-
sectional area that is available to handle the same load that would be handled in a 
concentric contraction (3). 
Damage to muscle structures has been shown to occur following a bout of 
strenuous exercise. Muscle damage can be manifested as a loss in muscle function or 
mechanical disruptions in the muscle architecture. The functional implications of muscle 
damage include a reduced range of motion in joints, stiffness, altered fatigability, reduced 
muscle shortening velocity, and prolonged strength loss in muscles (4). 
Eccentric exercises typically result in approximately 10-30% force loss 
immediately following exercise (5). High force eccentric exercise (exercise consisting of 
maximal eccentric actions) results in muscle strength loss of about 40-60% immediately 
after exercise, and strength is not fully recovered until about 10 days later (6; 7). Since 
muscle injury has an impact on performance in the workplace, home and on the athletic 
field, it is important to understand the mechanism behind muscle damage in order to 
devise means to prevent or reduce the detrimental effects. 
Immediately following eccentric contractions many sarcomeres show signs of 
disruption and damage. Newhan et al. (8) found single disrupted sarcomeres and 
disrupted half-sarcomeres, surrounded by normal appearing sarcomeres under the 
electron microscope, following eccentric contractions of human quadriceps muscles. In 
the disrupted sarcomeres the myofilaments were disorganized and Z-band material was 
seen to be "streamed" across the sarcomeres or a widening of the Z-band was apparent 
(8). Friden et al. (9) supported the findings of Z-band disorganization following 
eccentrically induced muscle damage in human soleus muscles. Following injury, the Z-
band material, which normally has a regular and discrete structure, was streamed and in 
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some cases there was a complete disruption, resulting in gaps in the lattice pattern, which 
peaked three days post exercise and decreased with time (9). 
Damage to the membrane or sarcoplasmic reticulum (SR) would allow calcium 
(Ca"+) to move down its concentration gradient from the extracellular space into the 
cytosol, potentially increasing the level of intracellular Ca2+ and resulting in a loss of 
calcium homeostasis. Duan et ah found that rat skeletal muscle had elevated 
mitochondrial Ca2+ levels following injury from downhill walking (10). High levels of 
Ca2+ have the potential to activate various molecular pathways in skeletal muscle, such as 
the calpain proteolytic pathways and the phospholipase A2 pathway. Calpains are 
thought to play a role in muscle damage by being responsible for the initial breakdown of 
myofibrils and cytoskeletal proteins (eg. desmin, a-actinin) (11). Activation of 
phospholipase hi pathway may contribute to further post-exercise muscle damage of the 
sarcolemma, thus increasing the loss of intracellular molecules (12). To further support 
the role that elevated Ca~+ plays in the injury process, it has been observed that when 
muscle fibres are treated with calcium chelators (EDTA and EGTA) there is a reduced 
accumulation of Ca2+ in the mitochondria that is accompanied by an attenuation in 
muscle fibre injury (10). The inability of skeletal muscle to buffer the damage related 
increase in intracellular Ca2+ may lead to further damage in the muscle. 
Structural alterations within the muscle are accompanied by the leakage of 
proteins such as myoglobin and creatine kinase (CK) out of the cell and into circulation. 
CK is a metabolic enzyme located intracellularly in muscles. Due to its location and 
solubility it is able to cross the muscle sarcolemma membrane if the membrane is 
damaged or disrupted. Therefore, measurements of CK release are an indirect indicator 
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of muscle membrane damage (13). Another common indicator of muscle damage is (3-
glucuronidase. Measurements of the activity of the lysosomal acid hydrolase (3-
glucuronidase have previously been shown to provide a quantitative indicator of exercise 
induced muscle damage (14). 
Performance of an exercise that causes muscle damage results in an adaptation in 
the muscle. One bout of high force eccentric exercise is enough to elicit an adaptation 
response in humans, such that the muscle is more resistant to damage and repairs at a 
faster rate with subsequent bouts of exercise (15). The repeated bout effect has been 
demonstrated not only in human but also in animal models, using various types of 
activities employing different muscle groups (16). Several theories have been proposed 
to explain the repeated bout effect, such as neural, connective tissue, or cellular 
adaptations (16), but the specific mechanism has yet to be identified. 
1.2 Skeletal Muscle Inflammation 
Damage to muscle results in an inflammation response at the site of injury. 
During inflammation, leukocytes, primarily neutrophils and monocytes/macrophages, 
perform a wide range of functions preparing for repair and regeneration of the damaged 
muscle. 
Neutrophils rapidly invade muscle when damage occurs, and are present at 
elevated levels when the injured fibres are being repaired. Neutrophils invade 
immediately following exercise and remain elevated for as long as 5 days post-exercise 
in humans (17). The time course varies with species but in general invasion of the 
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damaged tissue by neutrophils can persist for days to weeks. Neutrophils have been 
observed to peak 24 hrs following eccentric exercise in rats (18). 
Neutrophils, along with monocytes and macrophages, play a critical role in 
inflammation through removal of necrotic tissue cellular debris (19). Neutrophils release 
cytokines that can attract and activate additional inflammatory cells (19). Neutrophils 
assist in the degradation of damaged tissue or foreign matter primarily through their 
phagocytic ability (20). Additionally, muscle proteins in the damaged areas may be 
degraded by proteolytic systems introduced by infiltrating phagocytic cells, or by 
proteases intrinsic to the muscle (21). 
Neutrophils roll along the vessel wall searching the endothelium for signs of 
inflammation and chemoattractants that can activate and initiate their adhesion to the 
endothelium (22). At rest, more than half of the circulating neutrophils are located along 
the endothelial walls of blood vessels (22). In response to exercise, the increase in 
epinephrine, blood flow, and cell signaling molecules moves neutrophils away from the 
vessel walls and mobilize them into circulation, where they are redistributed to their 
required places in the body (23). In response to injury, the muscle cell communicates 
with the endothelium wall of the adjacent blood vessel, signaling the movement of 
neutrophils from circulation into the tissue. This communication is performed by a 
variety of cytokines. 
Cytokines are a diverse class of compounds that are extensively used for cellular 
communication. All nucleated cells in the body produce cytokines and express cytokine 
receptors on their surface membrane. Cytokines bind to a specific cell surface receptor 
triggering a cascade of intracellular signals that are capable of altering cellular functions. 
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Skeletal muscles produce cytokines such as, interleukin (IL) 1, 6 and 8, and tumour 
necrosis factor (TNF) (24), in an effort to regulate function and maintain homeostasis. In 
response to injury there is an increased expression of IL-1 and TNF-oc. These 
proinflammatory cytokines are responsible for upregulating the expression of endothelial 
leukocyte adhesion molecules and they play a role in initiating the breakdown of 
damaged muscle tissue (25). Activating the endothelium can cause the release of 
additional IL-1 and other proinflammatory cytokines, which recruit neutrophils to the site 
of injury (26). 
Additionally, oxygen radical formation by neutrophil bursts are important in 
clearing away the damaged muscle tissue. The 50 to 100 fold increase in oxygen 
consumption by neutrophils results in an increased production of cytotoxic oxygen 
species, and possibly reactive nitrogen species (27). Nitric oxide (NO) was found to have 
a protective effect on muscle cells from neutrophil mediated cytolysis in vitro (28). 
Conversely, superoxide or superoxide derivatives have a cystolic function in neutrophil 
mediated lysis of muscle cells in vitro (28). 
There may be secondary or collateral damage that occurs with neutrophil invasion 
of the muscle. When the generation of reactive radicals exceeds the ability of the tissue 
antioxidants to detoxify them, then the oxidative stress present can lead to further muscle 
damage (29). Release of high concentrations of cystolic and cytotoxic substances can 
damage healthy tissue (30). A fine balance has to be maintained since both 
overproduction and underproduction of superoxide by neutrophils can result in negative 
consequences. 
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Similar to neutrophils, macrophages are also capable of releasing reactive radicals 
and cytotoxic enzymes to aid in tissue degeneration. Macrophages are formed from 
undifferentiated monocytes circulating in the blood. In response to muscle damage 
macrophages invade the muscle and will concentrate near damaged fibres, and may even 
infiltrate the fibres (31). 
Two main subpopulations of macrophages have been identified, ED1+ and ED2+. 
ED1+ macrophages infiltrate muscle approximately 12-24 hours after exercise damage 
(32). It is thought that macrophages, especially ED1+ macrophages, are responsible for 
the phagocytosis of injured tissue and secretion of inflammation regulatory cytokines. 
However ED2+ macrophages are thought to contribute to satellite cell activation and 
proliferation in vivo (33). ED2+ macrophages infiltrate muscle during later regeneration 
phase and induce satellite cell activation (34). 
Activation of EDI+ macrophages further contributes to inflammation by 
producing and releasing a variety of substances, including proinflammatory cytokines 
such as prostaglandins and IL-1 (3 (35). Not only is the macrophage response enhanced in 
the tissue by cell signaling, but additional neutrophils are also recruited (35). Unlike 
neutrophils, macrophages, in particular ED2+, release growth factors necessary for 
muscle repair and regeneration. Most notable are the cell growth regulatory cytokines, 
such as insulin-like growth factor (IGF-1), fibroblast growth factor (FGF), and 
transforming growth factor-fjl (TGF-fil). These cytokines activate and recruit 
fibroblasts (36). Fibroblasts provide the structural framework in muscles and play a 
critical role in the repair process. Additionally, fibroblasts continue to secrete their own 
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proinflammatory cytokines during the repair process, further contributing to the feedback 
loop. 
1.3 Skeletal Muscle Repair 
Skeletal muscle has the capacity to adapt to the physiological stress placed on it 
by growth, training and injury. As the removal of damaged tissue occurs, muscle fibre 
regeneration occurs by activation of satellite cells. Macrophages are not only critical for 
the removal of damaged and necrotic cellular debris, but they also attract myogenic 
satellite cells to the site of injury and release cytokines that regulate the myogenic 
satellite cell pool (37). 
In undisturbed conditions, myogenic satellite cells remain in a non-proliferative, 
quiescent state. Myogenic satellite cells are undifferentiated stem cells. Quiescent 
myogenic satellite cells reside between the sarcolemma and the basal lamina. These cells 
contain little cytoplasm and few organelles (38). In response to muscle injury, satellite 
cells become activated and enter the cell cycle to provide the precursors required for new 
muscle formation during growth and repair (39). The ability of satellite cells to enhance 
muscle mass and repair muscle following injury makes them a vital component in 
skeletal muscle. 
In response to cellular and extracellular signals associated with muscle damage 
satellite cells exit their quiescent state and migrate to the site of injury to repair or replace 
damaged muscle fibres. The signaling cascade for satellite cell activation is 
accomplished through the activating agents, nitric oxide (NO) released from the fibres or 
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the release of HGF from the extracellular matrix (40). Activated satellite cells have 
hypertrophied organelles and an expanded cytoplasm (38). 
Following activation, satellite cells and myogenic precursor cells begin to 
proliferate (41). Committed myoblasts continue to proliferate and express muscle 
regulatory genes until the balance of protein expression drives the cells towards 
differentiation (42). Fibroblast growth factor stimulates an increase in the proliferation of 
satellite cells that have already been activated, however, it represses their ability to 
differentiate (43). Furthermore, insulin-like growth factor can activate proliferation and 
differentiation of satellite cells (43). Other factors that stimulate proliferation during 
muscle repair include HGF, LIF, GH, IL-6, insulin, leptin and testosterone (44). 
The third stage in skeletal muscle regeneration is differentiation. It is the process 
whereby proliferating myoblasts formed from activated satellite cells, and other 
myogenic precursors, leave the cell cycle and fuse with existing myofibres to repair 
damaged segments or fuse together to form new myofibres during regeneration of 
damaged skeletal muscle (45). Differentiation is initiated in response to cellular and 
extracellular signals associated with muscle damage. Some factors that influence 
differentiation of satellite cells have previously been listed, but also include LIF, GH, 
insulin, IL-15, leptin and testosterone (44). 
Following muscle regeneration the satellite cells return to a quiescent state. 
Myogenic satellite cells are self-renewing; the residual pool of satellite cells is re-
established after each bout of injury. This beneficial process ensures that the pool of 
satellite cells is not depleted and is made available for further rounds of regeneration. 
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The distribution of satellite cells has been found to be distinctly different in the 
relative number of satellite cells within oxidative and glycolytic muscles in animals. The 
more oxidative fibres in muscle generally have a larger population of satellite cells (46). 
Aged skeletal muscles are more prone than young ones to be susceptible to 
exercise-induced muscle damage and their regenerative capacity is also impaired (47; 
48). In the slow twitch muscle of the soleus and the fast twitch muscle of the extensor 
digitorum longus muscles of rats there is a decline in satellite cell content with age (49). 
In rats, the proliferation potential of satellite cells also decreases with age (47). Human 
studies have also observed the same results. In the study by Kadi et al. (50), they 
demonstrated that the satellite cell proportion is reduced in older adults compared to 
younger women and men, implying that there is a reduction in the satellite cell pool as 
age increases. 
1.4 Influence of Estrogen 
Estrogen hormones play a vital role in developing and maintaining normal sexual 
and reproductive functions in both humans and animals. They also influence a variety of 
tissues, such as the uterus, prostate, bone, breast, brain, colon, and muscle (51). The term 
estrogen refers to three structurally similar steroid hormones: estrone, estriol, and 
estradiol 17(3 (E2). E2 is the primary estrogen found within the body. 
The primary practical purpose of studying the effects of estrogen in response to 
skeletal muscle damage would be in order to gain further insight into the process in post-
menopausal women. Post-menopausal women have reduced estrogen levels, and 
10 
therefore may be more susceptible to muscle damage and have a slower recovery time 
than pre-menopausal women. 
In response to exercise-induced muscle damage, estrogen has been shown to 
reduce leukocyte derived inflammation (18). In particular, neutrophil infiltration into 
damaged muscle has been found to be reduced in response to estrogen supplementation 
(52). Recall that neutrophils increase inflammation post-exercise as they invade into the 
damaged muscles and produce oxidizing agents that are important in the clearance of 
damaged tissue debris (19-21; 53). It is postulated that a reduction in neutrophils is 
associated with a reduction in muscle damage, since neutrophils may exacerbate post-
exercise damage by the generation of the oxidizing agents. It has been demonstrated that 
exercised female ovariectomized rats that received estrogen administration display an 
attenuation in muscle damage (CK activity), leukocyte activity, neutrophil infiltration and 
calpain-like activities as compared to exercised, unsupplemented animals (52). 
Additionally, Tiidus and Bombardier (18) compared sexually mature male and female 
rats and found a significant decrease in neutrophil infiltration post-exercise in female rats. 
When the male rats were supplemented with estrogen, neutrophil infiltration was 
attenuated to levels found in females. A reduction in neutrophils may decrease the 
severity and time course of inflammation, potentially enhancing the healing process. 
Macrophages are also important in the removal of damaged muscle; additionally 
they are associated with the activation of muscle satellite cells and the repair process 
(39). St. Pierre-Schneider et al. (54) set forth to determine the time course of leukocyte 
invasion into damaged skeletal muscle of male and female mice. They reported a delay 
of macrophage migration to injured muscles of female mice compared to males by 
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several days following damage (54). McClung et al. (55) also found that a delay in 
macrophage invasion following injury was associated with differences in estrogen status. 
Ovariectomized female rats displayed an elevation in macrophage (ED1+ and ED2+) 
infiltration relative to intact female rats, seven days following injury (55). These studies 
demonstrate that macrophages are vital for a timely recovery from muscle damage and 
that estrogen plays a critical role in that process. 
In terms of satellite cell response, it has been found that estrogen supplemented 
rats had an increase in muscle satellite cell content as compared to the rats that did not 
receive estrogen supplementation (56). Recent work by Enns & Tiidus (57) has found 
that estrogen supplemented animals had increased numbers of total, activated and 
proliferating satellite cells compared to estrogen naive animals following exercise 
induced muscle damage. 
The mechanism by which estrogen influences the inflammation and repair process 
in damaged skeletal muscle is still uncertain. The proposed mechanisms for estrogen's 
effect may be through a direct nonspecific interaction with phospholipids, or by 
interactions with other membrane components, or even through an antioxidant effect. 
Understanding the mechanism behind estrogen's effects may allow us to optimize and 
manipulate this process. 
It has been suggested that estrogen may have a membrane stabilizing effect. 
Estrogen is a fat-soluble hormone, capable of incorporating into the lipid bilayer of the 
cell and stabilizing the membrane (58). It is thought that this interaction could alter the 
fluidity and function of the membrane. Estrogen may incorporate into cell membranes, 
similar to how cholesterol integrates, and may act in a comparable nature to optimize 
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membrane fluidity and polyunsaturated fatty acid arrangement (59). Therefore, estrogen 
may have the capacity to limit membrane disruption in response to damage by stabilizing 
the membranes. 
Additionally, estrogen may exert its effects through its antioxidant capacity. 
Antioxidants are molecules that have the ability to neutralize the unpaired electron from 
free radical species. Compounds with free radicals can cause chain reactions that damage 
cells. Antioxidants remove the free radical intermediates and terminate these potentially 
hazardous reactions. Estrogen possesses a hydroxyl group on its "A" (phenolic) ring, in 
the same position and configuration as found on the antioxidant vitamin E (60). Similar 
to vitamin E, estrogens may donate the hydrogen atoms from their phenolic hydroxyl 
group, halting the free radical peroxidation chain reactions (60). In this respect, exposure 
of skeletal muscle to estrogen may reduce muscle damage. 
An alternative mechanism for estrogen's effect may be by direct receptor 
mediated mechanisms. Skeletal muscle is known to possess a small number of 
membrane bound estrogen receptors. Two estrogen receptors (ERs), ERa and ERp\ have 
been characterized and are expressed in mammalian skeletal muscle (61; 62). The 
specific roles that estrogen and its receptors serve in the muscle damage and repair 
processes remain elusive. The proliferative actions of estrogen seem to require EPoc; 
whereas the differentiative and anti-proliferative effects of estrogen may be controlled by 
ERP in ovaries (63). Therefore, the relative tissue distribution of the estrogen receptors 
may be a determinant in their form of action. Lemoine et al. (62) found that ERa levels 
in (untrained rats') skeletal muscle are distributed differently. Slow twitch muscle 
(soleus) had the greatest amount of ERa levels compared with an intermediate muscle 
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(gastrocnemius) and a fast twitch muscle (extensor digitorum longus) (62). These results 
are in agreement with those found in rabbits (64). Furthermore, it has been demonstrated 
that ERa and ER(3 levels can be upregulated with exercise (65; 66). 
Estrogen influences a variety of physiological and metabolic events within 
muscle. It has already been stated that estrogen contributes to the inflammatory and 
repair processes following skeletal muscle damage. Similar to the mechanisms behind 
estrogen's effects, the signaling processes also need further investigation. To date, it is 
known that estrogen influences the induction of heat shock proteins (HSPs). Heat shock 
proteins are highly conserved stress proteins that are induced in response to stressors, 
such as exercise and muscle damage (67). Their primary function is to act as chaperones, 
to mediate the proper folding of denatured proteins (68). Exercise induced muscle 
damage results in an increase in intracellular denatured proteins, signaling the induction 
of the HSP response. A relationship between the induction of the HSP response and a 
reduction in damage has been demonstrated in cardiac muscle. The induction of HSPs 
resulted in cardioprotection and delayed the onset of myocardial injury caused by 
ischemia (69). Paroo et al. (70) found a gender specific HSP response in rats. They 
found that males displayed a greater induction of HSP70 in skeletal muscle than females 
post-exercise (70). Moreover, ovariectomized rats supplemented with estrogen 
demonstrated a reduction in HSP70 levels compared to placebo treated ovariectomized 
rats, suggesting an estrogen mediated response (70). In support of these findings, it has 
been shown that male rats supplemented with estrogen resulted in a HSP response similar 
to those of females following exercise (71). 
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1.5 Influence of Progesterone 
Progesterone receptors are distributed in numerous tissues. In rats they have been 
found to exist in the reproductive glands, certain regions of the oral mucosa and 
developing teeth, esophagus, larynx, skin, mammary gland, kidney, and skeletal muscle 
(72). 
There has been limited work on the mechanism of progesterone's effect, but what 
is known is that there is a similar distribution of estrogen and progesterone receptors in 
most of the same cell types and tissues which may suggest that estrogen is involved in 
progesterone receptor induction (72). In the uterus, progesterone's effect is mediated by 
its receptors and estrogen increases progesterone receptor levels (73). 
The interaction effects of progesterone and estrogen are limited, but it has been 
demonstrated that the combined supplementation influences skeletal muscle fatigue (74). 
In the study by St. Pierre-Schneider et al. (74) it was found that the time to fatigue was 
greatest in ovariectomized mice treated with progesterone alone, even more so than 
ovariectomized mice treated with placebo or a combination of estrogen and progesterone. 
Furthermore, it was found that the ovariectomized mice treated with progesterone alone 
had the greatest percent of isometric torque remaining immediately after eccentric 
contractions, as compared to the ovariectomized mice treated with placebo, estrogen, or a 
combination of estrogen and progesterone (74). 
A related study done by Xing et al. (75) used the rat model to demonstrate the 
effects that hormones had on leukocyte content in response to endothelium vascular 
injury. They demonstrated that estrogen attenuated leukocyte populations and migration 
into injured tissue. The addition of progesterone and estrogen in combination negated the 
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protective effect observed by estrogen alone. Additionally, progesterone administration 
alone had no independent effect of leukocyte infiltration following damage (75). 
The mechanism behind progesterone's actions has yet to be determined. 
Additionally, the interaction effects of progesterone and estrogen still need to be explored 
in order to determine their physiological significance. The practical implications of 
exploring this area may be for post-menopausal females that could be more prone to 
muscle injury. These women have altered hormone levels when they enter menopause 
and hormone intervention strategies involving estrogen and progesterone may be of 
importance. Additionally, further knowledge of the mechanisms behind muscle 
inflammation can be optimized (e.g., ER involvement and estrogen/progesterone 
interaction) to develop pharmaceutical or other intervention strategies to aid the skeletal 
muscle inflammatory process. 
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Chapter Two 
Influence of Estrogen Receptor Blockage on Indices of Skeletal Muscle 
Inflammation 
Statement of Problem 
The purpose of this study was to investigate the role of estrogen receptors (ER) on 
muscle leukocyte (neutrophil and macrophage) infiltration following eccentric exercise 
through administration of the ER antagonist ICI182, 780 to ovariectomized female rats 
with or without estrogen supplementation. 
Subsidiary Problem 
A secondary objective was to examine differences in leukocyte infiltration in skeletal 
muscle of different fibre types. 
Hypotheses 
1. It is hypothesized that leukocyte infiltration will be attenuated with estrogen 
supplementation. 
2. ER blocker administration will negate the attenuation of leukocytes induced by 
estrogen supplementation. 
3. Based on previous studies it is thought that both fast and slow muscle types will 
display similar trends in leukocyte infiltration. 
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Introduction 
Unaccustomed strenuous exercise, especially eccentric exercise can cause muscle 
damage. Muscle damage can be manifested as a loss in muscle function or mechanical 
disruptions in the muscle architecture. Damage to muscle results in an inflammation 
response at the site of injury. During inflammation, leukocytes, primarily neutrophils 
and monocytes/macrophages perform a wide range of functions preparing for repair and 
regeneration of the damaged muscle. 
Neutrophils rapidly invade muscle when damage occurs, and are present at 
elevated levels when the injured fibres are being repaired. Neutrophils invade 
immediately following exercise and remain elevated for as long as 5 days post-exercise 
in humans (76). Neutrophils have been observed to peak 24 hrs following eccentric 
exercise in rat (18). Neutrophils, along with monocytes and macrophages, play a critical 
role in inflammation through removal of necrotic tissue cellular debris (19). In response 
to muscle damage macrophages invade the muscle and will concentrate near damaged 
fibres, and may even infiltrate the fibres (77). Two main subpopulations of macrophages 
have been identified, ED1+ and ED2+. ED1+ macrophages infiltrate muscle 
approximately 12-24 hr after exercise induced damage (19). It is thought that 
macrophages, especially ED1+ macrophages, are responsible for the phagocytosis of 
injured tissue and secretion of inflammation regulatory cytokines. In contrast, ED2+ 
macrophages are thought to contribute to satellite cell activation and proliferation in vivo 
(33). 
In response to exercise-induced muscle damage, estrogen has been shown to 
reduce leukocyte derived inflammation (18). In particular, neutrophil infiltration into 
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damaged muscle has been found to be reduced in response to estrogen supplementation 
(52). It has been demonstrated that exercised female ovariectomized rats that received 
estrogen administration display an attenuation in muscle damage (CK activity), leukocyte 
activity, neutrophil infiltration and calpain-like activities as compared to exercised, 
unsupplemented animals (52). Additionally, Tiidus and Bombardier (18) compared 
sexually mature male and female rats and found a significant decrease in neutrophil 
infiltration post-exercise in female rats. When the male rats were supplemented with 
estrogen, neutrophil infiltration was attenuated to levels found in females. A reduction in 
neutrophils may decrease the severity and time course of inflammation, potentially 
enhancing the healing process. St. Pierre-Schneider et al. (54) set forth to determine the 
time course of leukocyte invasion into damaged skeletal muscle of male and female mice. 
They reported a delay in leukocyte migration to injured muscles of female mice 
compared to males by several days following damage (54). McClung et al. (55) also 
found that a delay in macrophage invasion following injury was associated with 
differences in estrogen status. Ovariectomized female rats displayed an elevation in 
macrophage (ED1+ and ED2+) infiltration relative to intact female rats, seven days 
following injury (55). 
The mechanism by which estrogen influences the inflammation and repair process 
in damaged skeletal muscle is still uncertain. Estrogen may exert its effect via direct 
receptor mediated mechanisms. Skeletal muscle is known to process a small number of 
membrane bound estrogen receptors. Two estrogen receptors (ERs) ERoc and ER(3 have 
been characterized and are expressed in mammalian skeletal muscle (61; 62). The 
specific roles that estrogen and its receptors serve in the muscle damage process remain 
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elusive. Slow twitch muscle (soleus) had the greatest amount of ERoc levels compared 
with an intermediate muscle (gastrocnemius) and a fast twitch muscle (extensor 
digitorum longus) (62). These results are in agreement with those found in rabbits (64). 
Furthermore, it has been demonstrated that ERa and ER(3 levels can be upregulated with 
exercise (65; 66). 
In this study, we investigated the role of estrogen receptors (ER) on muscle 
leukocyte (neutrophil and macrophage) infiltration following eccentric exercise through 
administration of the pure ER antagonist ICI 182, 780 to ovariectomized female rats with 
or without estrogen supplementation. The pure ER blocker binds with an extremely high 
affinity and specificity to both ER a and (3 and possesses no estrogen agonistic properties 
(78). Alternatively, estrogen may act via non-receptor mediated mechanisms, such as 
direct interactions with other membrane components, or even through an antioxidant 
effect. 
We quantified the effects of estrogen supplementation and ICI 182, 780 
administration on neutrophil and macrophage infiltration in red and white fibre types of 
rat skeletal muscle following downhill running. The neutrophil marker His48 and the 
macrophage marker EDI were quantified 24 hr post-exercise. In addition to measuring 
leukocyte infiltration, muscle damage was indirectly assessed by measuring (3-
glucuronidase activity. 
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Methods 
Animals 
The study was approved by the Animal Care Committee at Wilfrid Laurier University 
and all procedures were performed in accordance with the Canada Council on Animal 
Care. A total of 72 ovariectomized female Sprague-Dawley rats (Charles River 
Laboratories, LaSalle, QC) were used in this study. The ovaries were surgically removed 
at 9 weeks of age, and all animals were 10 weeks old upon arrival in our laboratory. 
Animals were housed two per cage in an environmentally controlled environment with a 
standard 12:12 light/dark cycle and allowed access to food (Tekland 22/5 Rodent Diet, 
Harland-Tekland, Madison, WI) and water ad libitum. 
Experimental Design 
Following one week of acclimation in the laboratory, animals were randomly subdivided 
into either the estrogen supplementation group or into the group receiving a sham 
procedure. Half of the estrogen supplemented animals received injections of the pure 
estrogen receptor blocker, ICI 182, 780, while the remaining animals received vehicle 
injections. Each of these groups were further subdivided into exercise (sacrificed 24 and 
72 hr post-exercise) and a control (unexercised) group, as illustrated in Figure 1. Thus 
nine groups of rats (n = 7-9 rats per group) were used in this study. 
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Ovariectomized female rats 
n=72 
Sham 
n=25 
Estrogen 
n=23 
Estrogen + ICI 182,780 
n=24 
CON 
n=9 
EX 
n=16 
24 h 
n=8 
72 h 
n=8 
CON 
n=8 
EX 
n=15 
24 h 
n=8 
72 h 
n=7 
CON 
n=8 
/ 
24 h 
n=8 
EX 
n=16 
/ \ 
\ 
72 h 
n=8 
Figure 1: Schematic outline of the experimental protocol. CON = control (unexercised) 
condition; EX = exercised condition. 
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One day prior to and 6 days following estrogen pellet implantation (or sham 
procedure), animals were injected with either ICI 182, 780 (5 mg kg" s.c, dissolved in 
DMSO and diluted in corn oil, Cookson Inc., Ellisville, MO, USA) or a placebo (corn 
oil/DMSO) solution. 
The estrogen pellet implantation and sham procedures were performed under 
aseptic conditions. Rats were anaesthetized via inhaled isoflurane, and a small incision 
was made in the skin folds of the neck. Blunt dissection was used to separate the skin 
from the underlying fascia. For the estrogen-supplemented animals, the estrogen pellet 
0.25 mg 17(3-estradiol, 21-day time release pellet (Innovative Research of America, 
Sarasota, FL) was inserted under the skin approximately 1 cm from the site of incision 
using forceps. For the sham procedure, blunt dissection and insertion of the forceps was 
performed similar to estrogen pellet procedure, but without a pellet insertion. The 
incision was sealed with Vetabond (3M St. Paul, MN). Animals were allowed to recover 
for 8 days prior to beginning the exercise protocol. This recovery time also allowed the 
pellet implanted groups to receive prolonged exposure to estrogen. 
The animals being exercised were exposed to 5 minute familiarization sessions, 
one and two days prior to performing the exercise protocol. The animals ran on a 
motorized rodent treadmill with an electric shock grid (Columbus Instruments, 
Columbus, OH). The exercised animals ran on the treadmill at a -13.5° grade at a speed 
of 17 m/min. They ran for a total of 90 min using an intermittent protocol of 5 min 
running interspersed with 2 min of rest, as described elsewhere (79). This protocol is 
non-fatiguing and has been shown to elicit damage in the soleus and white vastus muscles 
in rodents (14; 80). 
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Tissue collection 
All animals were sacrificed by an overdose of sodium pentobarbital (55 mg/kg i.p.). The 
exercised animals were sacrificed at 24 and 72 hours post-exercise. The control animals 
were euthanized at the same time as the exercised animals. Anesthesia was confirmed 
with the loss of withdrawal reflex from a toe web pinch. During sacrifice, the lower 
abdomen was opened and a blood sample (5 mL) was withdrawn from the descending 
aorta. Blood was allowed to clot, and centrifuged for 10 minutes at 3000 g. The serum 
was removed and stored at -20°C. The soleus and superficial (white) portion of the 
vastus muscle and uterus were removed. These muscle regions contain predominately 
Type I and Type lib fibres, respectively (81). Tissue samples were thoroughly rinsed in 
physiological saline to remove excess blood, blotted dry and trimmed of visible 
connective tissue and tendons and also weighted in the case of the uteri to determine wet 
weight. The uteri were then dried in the oven to determine dry weight values. The fibres 
of the muscle were properly aligned and the muscle samples were mounted and coated in 
optimal cutting temperature (OCT) medium and quickly frozen in isopentane chilled to 
the temperature of liquid nitrogen, in preparation for immunohistochemical analysis. All 
tissue samples were immediately placed in liquid nitrogen, then stored at -20°C until 
analysis. 
Serum Estrogen Assay 
Serum estrogen levels were analyzed (in duplicate) using a commercially available 
radioimmunoassay (RIA) kit (Coat-a-Count TKE21, Inter Medico, Markham, ON). 
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^•Glucuronidase Activity Assay 
p-glucuronidase activity was measured in the muscle samples using the method of Barrett 
(82) as described by Koskinen et al. (83). Samples were assayed (in triplicate) at 420 nm. 
Samples were expressed as the amount of substrate (5 mM p-nitrophenyl-p-D-
glucuronide, Sigma-Aldrich) hydrolyzed per amount of protein and incubation time. To 
determine the total protein content in the samples the Lowry Protein Assay was 
performed (84). 
Lowry Protein Assay to Determine Total Protein Content 
Total protein content in muscle homogenates was measured using the Lowry Protein 
Assay (84). Each sample was assayed (in triplicate) at 650 nm. Measured protein values 
were corrected against a "blank" (water sample) and compared against a bovine serum 
albumin standard (Sigma-Aldrich, St. Louis, MO). 
Immunohistochemistry to Determine Inflammatory Response 
Neutrophil and macrophage cells in soleus and white vastus muscles were determined by 
sectioning the muscles onto Vectabond coated glass slides (Vector Laboratories, 
Burlington, ON). Transverse serial sections of soleus and white vastus muscles were cut 
at 7 (J,m using a cryostat (Leica CM3050S, Germany) at -20°C. The slides were stored at 
-20°C until staining. Sections were immunostained for the leukocyte markers: His48 
(present primarily on neutrophils) (85) and EDI (present primarily on macrophages) (86). 
To quantify the cells, slides were placed under a light microscope (Leica DMLS) 
with the image projected onto a computer screen at a magnification of 400x (lOx ocular 
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and 40x objective lens). Twenty random fields were selected and ten fibres from those 
fields were analyzed. This procedure was performed on two different cross sections of 
the same muscle, for a total of 400 fibres being analyzed from each sample. Cells on the 
outer edges of the cross section and those present in the blood were excluded during 
quantification. Figure 2 depicts representative positive cells that were used during the 
quantification of leukocytes. 
Statistical Analysis 
All data are presented as means ± SEM. Differences between groups were measured 
using a 2 (exercise) by 3 (conditions) factorial ANOVA at a level of significance of 
P < 0.05. Where significance was obtained, post-hoc multiple comparison testing was 
done using a Bonferroni test to determine where specific differences had occurred. 
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Figure 2: Representative images showing sections (7 |im) of rat skeletal muscles 
immunostained for (A) neutrophils (His48) and (B) macrophages (EDI) (400x 
magnification). 
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Results 
Serum Estrogen Levels 
Since exercise and time of sacrifice had no effect on serum estrogen levels, animals were 
pooled into three groups according to their supplementation status: sham, estrogen-
supplemented and estrogen-supplemented plus blocker (ICI 182,780) groups. As 
depicted in Table 1, estrogen administered rats had significantly higher (P < 0.05) serum 
estrogen levels relative to sham (unsupplemented) rats. Furthermore, serum estrogen 
levels of estrogen-supplemented plus blocker (IC 182, 780) animals were significantly 
greater (P < 0.05) than both sham animals and those that received estrogen alone. There 
was no significant difference (P > 0.05) between estrogen-supplemented animals and 
those receiving both estrogen supplementation plus blocker (ICI 182,780). 
Body Weights 
All groups continued to gain weight throughout the experimental period. However, sham 
(unsupplemented) animals were significantly heavier than estrogen only treated animals 
and estrogen plus ER antagonist supplemented animals at the time of sacrifice (P < 0.05), 
as depicted in Table 2. There was no significant weight difference between estrogen 
supplemented and estrogen plus ER antagonist supplemented groups (P > 0.05) at 
sacrifice. These data are in line with previous work demonstrating that estrogen 
administration to estrogen naive animals results in reduced body weight gain and lower 
body mass (52; 57) than sham (unsupplemented) animals. Age matched animals were 
chosen for the present study because weight matching between the groups would have 
involved using estrogen treated and estrogen plus ER antagonist supplemented animals of 
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higher age than sham animals. Since the present study was interested in using adult 
female rats, the experimental design avoids differences in age and age-related differences 
in hormonal status as confounding factors. 
Uterus Weights 
Estrogen binding to uterine estrogen receptors stimulates uterine growth; whereas binding 
of a receptor antagonist, such as ICI 182,780 to ERs will inhibit uterine growth (87). As 
depicted in Table 2, estrogen supplementation resulted in significantly greater (P < 0.05) 
uterus wet and dry weights compared to sham (unsupplemented) animals. Administration 
of blocker also resulted in significantly higher wet weight and dry weight relative to the 
sham animals (P < 0.05). Additionally, the blocker group had a 22% lower uterus wet 
weight and a 38% lower uterus dry weight compared to estrogen administration alone 
(P < 0.05). When the weights were normalized to overall body weights of the rats, these 
same trends were observed. 
^-Glucuronidase Activity 
To determine whether the exercise protocol resulted in lower exercised induced muscle 
damage in estrogen supplemented animals relative to estrogen naive animals, 
measurements of the activity of the lysosomal acid hydrolase, ^-glucuronidase were 
assessed. Indeed, estrogen supplemented animals displayed significantly less (P < 0.05) 
(3-glucuronidase activity 72 hours post-exercise than ovariectomized females in the soleus 
and white vastus muscles, as depicted in Table 3. In ovariectomized animals, 
administration of estrogen plus ICI 182, 780 significantly attenuated (P < 0.05) |3-
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glucuronidase activity 72 hours post-exercise in soleus and white vastus muscles, relative 
to sham (unsupplemented) animals; similar to the effects of estrogen only 
supplementation. 
Leukocytes Infiltration 
Leukocyte infiltration was measured by immunostaining for the neutrophil marker, 
His48, and the macrophage marker, EDI. A main effect with exercise was observed in 
neutrophils and macrophages, with control (unexercised) animals demonstrating 
significantly lower (P<0.05) leukocyte content compared to animals 24 hours after 
exercise in both muscle types. Increased neutrophil infiltration was observed 24 hours 
after exercise (Figures 3 and 4). A significant increase was observed in the soleus and 
white vastus muscle post-exercise (P < 0.05). In addition, macrophage infiltration was 
significantly increased (P < 0.05) post-exercise in both muscle types (Figures 5 and 6). 
Post-exercise, leukocyte infiltration was significantly reduced (P < 0.05) in estrogen 
supplemented animals compared to sham animals. Estrogen supplementation attenuated 
neutrophil infiltration by 33% in the white vastus muscle. Administration of estrogen 
reduced macrophage infiltration by 37 and 36% in the soleus and white vastus, 
respectively. The estrogen receptor antagonist, ICI 182, 780 did not significantly alter 
the attenuating affect of estrogen on neutrophil and macrophage infiltration in both 
muscle types. 
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Table 1: Animal body weights and serum estradiol levels for sham, estrogen and 
estrogen + ICI 182, 780 treatment groups. Values are pooled means + SEM.a P < 0.05 
compared to sham treated. P < 0.05 compared to estrogen-supplemented. 
Treatment Body Weight (g) Serum Estrodiol (pg ml"1) 
Sham 294 ± 4 12.5 ± 1 
Estrogen 260 ± 3 a 79.3 ± 15a 
Estrogen + 
ICI 182, 780 260 ± 3a 141.6 ±28.6ab 
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Table 2: Changes of uterus weights with estrogen status. Values are pooled means + 
SEM.a P < 0.0; 
supplemented. 
.a   . 5 compared to sham treated. b P < 0.05 compared to estrogen 
Wet weight, g 
Wet weight, g per 100 g body weight 
Dry weight, g 
Dry weight, g per 100 g body weight 
Sham 
0.098 ± 0.005 
0.033 ± 0.002 
0.027 ± 0.003 
0.009 ± 0.001 
Estrogen 
0.396+ 0.0213 
0.154 ±0.009a 
0.098 ± 0.009a 
0.038 ± 0.004a 
Estrogen + 
ICI 182,780 
0.313 ±0.016ab 
0.120 ±0.006ab 
0.061 ±0.003ab 
0.024 ±0.001a,b 
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Table 3: Changes in muscle (3-Glucuronidase activity with downhill running. Values are 
means + SEM.a P < 0.05 compared to unexercised controls. b P < 0.05 compared to 
sham treated. 
Soleus 
White Vastus 
Control 
Exercise + 24 h 
Exercise + 72 h 
Control 
Exercise + 24 h 
Exercise + 72 h 
Sham 
5.26 + 0.27 
6.49 ± 0.40a 
8.04 ± 0.88a 
4.71+0.39 
5.86 ± 0.45a 
6.19±0.57a 
Estrogen 
4.55 ±0.20 
4.77 ±0.33 
5.11 ±0.41b 
4.04 ±0.21 
3.90 ± 0.20b 
3.83 ±0.12" 
Estrogen + 
ICI 182,780 
4.46 ± 0.29 
4.94 ± 0.48 
4.97 ± 0.38b 
3.72 ± 0.40 
3.62±0.28b 
3.54±0.33b 
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Figure 3: Effects of estrogen supplementation and ICI 182,780 administration on 
numbers of His48+ neutrophils in rat soleus (red) muscle 24 h following downhill 
running. Values are means + SEM.a P < 0.05 compared to Control (unexercised). 
b
 P < 0.05 compared to Sham treated 
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Figure 4: Effects of estrogen supplementation and ICI 182,780 administration on 
numbers of His48+ neutrophils in rat white vastus muscle 24 h following downhill 
running. Values are means + SEM.a P < 0.05 compared to Control (unexercised). 
b
 P < 0.05 compared to Sham treated 
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Figure 5: Effects of estrogen supplementation and ICI 182,780 administration on 
numbers of EDI + macrophages in rat soleus (red) muscle 24 h following downhill 
running. Values are means + SEM. a P < 0.05 compared to Control (unexercised). 
b
 P < 0.05 compared to Sham treated. 
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Figure 6: Effects of estrogen supplementation and ICI 182,780 administration on 
numbers of EDI + macrophages in rat white vastus muscle 24 h following downhill 
running. Values are means + SEM.a P < 0.05 compared to Control (unexercised). 
b
 P < 0.05 compared to Sham treated. 
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Discussion 
The primary goal of this study was to gain further insight into the mechanism by 
which estrogen exerts its effects. It has been well established that estrogen reduces post-
exercise skeletal muscle damage. However, what is unknown is the mechanism behind 
estrogen's effects. We took the approach of examining the influence of estrogen 
receptors on estrogen effects on muscle leukocyte inflammation. We blocked the 
estrogen receptors with ICI 182, 780 to see if this altered estrogen's action on these 
parameters. 
Previously, tamoxifen has been used as an estrogen receptor blocker, however the 
results from these experiments should be interpreted with caution due to tamoxifen's dual 
properties. Not only does tamoxifen have estrogen antagonistic properties but it also 
possesses agonistic characteristics (88). The use of a pure estrogen receptor blocker, 
such as ICI 182, 780 provides more precise answers. This pure ER blocker binds with an 
extremely high affinity and specificity to both ER a and B and possesses no estrogen 
agonistic properties (78). The relative binding affinity of ICI 182, 780 to ERs is 0.89, 
whereas the affinity of estrogen for its receptors is 1.0 (78). To verify the ovariectomy 
was performed correctly and to quantify the biological response to treatment with 
estrogen and ICI 182, 780, the uteri were weighed. ICI 182, 780 effectively blocked ERs, 
as depicted by the significantly lower uterus wet and dry weights relative to the estrogen 
only supplemented group. 
As would be expected, estrogen only supplemented animals and those receiving 
estrogen plus the blocker had significantly higher serum estradiol levels compared to the 
unsupplemented ovariectomized animals. These levels are considered to be on the upper 
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end of the physiological range and consistent with 17p-estradiol replacement values 
found in other laboratories and our own (52; 89). The range of circulating estradiol levels 
is quite large and variable. Age and stage of estrus cycle contribute to this variability. 
Reported estradiol levels range as high as 285 pg ml"1 (90) to values such as 15 pg mf1 
(91). 
A major finding of the present study was the estrogen specific inflammatory 
response; with estrogen supplementation animals demonstrated an attenuation of 
leukocyte infiltration in skeletal muscle post-exercise compared to sham ovariectomized 
animals. Furthermore, this differential response also appears to be affecting the degree of 
muscle damage, as depicted by the lower (3-glucuronidase activity in estrogen 
supplemented rats compared to sham ovariectomized rats. Moreover, the results suggest 
that the mechanism by which estrogen is influencing this response is through a non-
estrogen receptor mediated process. Although the present study does not directly assess 
the involvement of the estrogen receptor as the mechanism behind estrogen's effects, if a 
casual relationship exists, the administration of the ER antagonist, ICI182, 780 should 
block estrogen's effect. However, ICI 182, 780 did not alter the ability of estrogen to 
protect against skeletal muscle damage. There was no significant difference in P-
glucuronidase activity between the animals that received estrogen supplementation alone 
and those that received estrogen plus the ER antagonist. Furthermore, treatment of the 
ovariectomized estrogen supplemented rats with ICI 182, 780 did not alter the leukocyte 
inflammatory response to exercise relative to those treated with estrogen alone, indicating 
that the hormonal mechanism is not primarily receptor mediated. 
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Alternatively, the results suggest a possible enhanced muscle sarcolemma stability 
with estrogen supplementation as the mechanism by which estrogen may influence 
leukocyte infiltration and damage. Duan et al. found that rat skeletal muscle had elevated 
mitochondrial Ca2+ levels following injury from downhill walking (10). High levels of 
Ca2+ have the potential to activate various molecular pathways in skeletal muscle, such as 
the calpain proteolytic pathways and the phospholipase A2 pathway. Calpains are 
thought to play a role in muscle damage by being responsible for the initial breakdown of 
myofibrils and cytoskeletal proteins (eg. desmin, a-actinin) (11). Activation of 
phospholipase A2 may contribute to the role of muscle damage by further damaging the 
sarcolemma and thus increasing the loss of intracellular molecules. To further support the 
role that elevated Ca"+ plays in the injury process, it has been observed that when muscle 
fibres are treated with chelators (EDTA and EGTA) there is a reduced accumulation of 
Ca"+ in the mitochondria, that is accompanied by an attenuation in muscle fibre injury 
(10). 
Another possible mechanism for estrogen's effects may be through the induction 
of heat shock proteins. Exercise induced muscle damage results in an increase in 
intracellular denatured proteins, signaling the induction of the HSP response to mediate 
the proper folding of denatured proteins (68). A relationship between the induction of 
the HSP response and a reduction in damage has been demonstrated in cardiac muscle. 
The induction of HSPs resulted in cardioprotection and delayed the onset of myocardial 
injury caused by ischemia (69). There is an intrinsic gender HSP response in rats, with 
males displaying a greater induction of HSP70 in skeletal muscle than females post-
exercise (70). Additionally, it has been shown that male rats supplemented with estrogen 
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resulted in a HSP response similar to those of females following exercise (71). 
Therefore, it is speculated that estrogen may exert its effect through one of the non-
estrogen receptor mediated mechanisms, such as HSP induction or estrogenic 
stabilization of the sarcolemma. 
In summary, estrogen administration affected post-exercise leukocyte 
inflammation. Estrogen administration attenuated post-exercise neutrophil and 
macrophage content compared to estrogen naive animals. Combined estrogen plus ER 
antagonist administration did not significantly alter the attenuation observed by estrogen 
only administration. Hence, estrogen receptors may not be the primary mechanism by 
which estrogen affects leukocyte inflammation. 
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Chapter Three 
The Effects of Progesterone on Estrogen Influence on the Indices of Skeletal Muscle 
Inflammation 
Statement of Problem 
The purpose of this study was to examine the specific and interaction effects of estrogen 
and progesterone on skeletal muscle in response to exercise induced damage. 
Subsidiary Problem 
A secondary objective was to examine differences in leukocyte infiltration in skeletal 
muscle of different fibre types. 
Hypotheses 
1. It is hypothesized that leukocyte infiltration will be attenuated with estrogen 
supplementation. 
2. It is believed that the addition of progesterone and estrogen in combination will 
negate the attenuation of leukocyte infiltration by estrogen supplementation alone. 
3. It is hypothesized that progesterone administration alone will have no independent 
effect on leukocyte infiltration. 
4. Based on previous studies it is thought that both fast and slow muscle types will 
display similar trends in leukocyte infiltration. 
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Introduction 
Muscle damage resulting from eccentric exercise can elicit leukocyte infiltration 
at the site of injury. Neutrophils invade immediately following exercise and assist in the 
degradation of damaged debris with their phagocytic and oxidative abilities (19; 92). 
Macrophages infiltrate muscle approximately 12-24 hours post-exercise (19). They are 
responsible for the removal of injured muscle debris, secretion of inflammation 
regulatory cytokines and satellite cell activation (19; 20; 33). 
Estrogen can influence the degree of exercise-induced muscle injury. Previous 
work from our laboratory has demonstrated attenuating effects of estrogen on post-
exercise leukocyte infiltration (52) and enhanced muscle satellite cell activation (57). It 
has been demonstrated that female ovariectomized rats that received estrogen 
administration demonstrated an attenuation in muscle damage (CK activity), leukocyte 
activity, neutrophil infiltration and calpain-like activities as compared to unsupplemented 
animals post-exercise (52). 
There has been limited work on the mechanism of progesterone's effect, but what 
is known is that there is a similar distribution of estrogen and progesterone receptors in 
most of the same cell types and tissues which may suggest that estrogen is involved in the 
progesterone receptor induction (72). In the uterus, progesterone is mediated by its 
receptors and estrogen increases progesterone receptor levels (73). Progesterone 
receptors are distributed in numerous tissues. In rats they have been found to exist in the 
reproductive glands, certain regions of the oral mucosa and developing teeth, esophagus, 
larynx, skin, mammary gland, kidney, and skeletal muscle (72). 
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The interaction effects of progesterone and estrogen are limited, but it has been 
demonstrated that the combined supplementation influences skeletal muscle fatigue (74). 
In the study by St. Pierre Schneider et al (74), it was found that the time to fatigue was 
greatest in ovariectomized mice treated with progesterone alone, even more so than 
ovariectomized mice treated with placebo or a combination of estradiol and progesterone. 
Furthermore, it was found that the ovariectomized mice treated with progesterone alone 
had the greatest percent of isometric torque remaining immediately after eccentric 
contractions, as compared to the ovariectomized mice treated with placebo, estradiol, or a 
combination of estradiol and progesterone (74). 
A related study by Xing et al. (75), used the rat model to demonstrate the effects 
that hormones had on leukocyte content in response to endothelium vascular injury. 
They demonstrated that estrogen attenuated leukocyte populations and migration into 
injured tissue. The addition of progesterone and estrogen in combination negated the 
protective effect observed by estrogen alone. Additionally, progesterone administration 
alone had no independent effect of leukocyte infiltration following damage (75). 
In this study, we examined the specific and interaction effects of estrogen and 
progesterone on skeletal muscle in response to injury. We quantified the effects of 
progesterone and estrogen supplementation on leukocyte (neutrophil and macrophage) 
infiltration in red and white fibre types of rat skeletal muscle following downhill running. 
The neutrophil marker His48 and the macrophage marker EDI were quantified 24 hr 
post-exercise. In addition to measuring leukocyte infiltration, muscle damage was 
indirectly assessed by measuring p-glucuronidase activity. 
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Methods 
Animals 
The study was approved by the Animal Care Committee at Wilfrid Laurier University 
and all procedures were performed in accordance with the Canada Council on Animal 
Care. A total of 63 ovariectomized Sprague-Dawley rats (Charles River Laboratories, 
LaSalle, QC) were be used. One animal was removed from the study due to illness. The 
animals had their ovaries removed at 9 weeks and be delivered at 10 weeks old. Animals 
were housed two per cage in an environmentally controlled environment with a standard 
12:12 light/dark cycle and allowed access to food (Tekland 22/5 Rodent Diet, Harland-
Tekland, Madison, WI) and water ad libitum. 
Experimental Design 
Following one week of acclimation in the laboratory, animals were being randomly 
subdivided into four groups: estrogen supplemented group, progesterone supplemented 
group, progesterone plus estrogen supplemented group or into the group receiving a sham 
procedure. The groups were further subdivided into exercise or control (unexercised) 
groups. 
45 
Sham 
n=16 
Ovariectomized female rats 
n=63 
Estrogen 
n=16 
Progesterone 
n=16 
CON 
n=8 
EX 
n=8 
CON 
n=8 
EX 
n=8 
CON EX 
n=8 n=8 
Estrogen + 
Progesterone 
n=15 
CON EX 
n=8 n=7 
Figure 7: Schematic outline of the experimental protocol. CON = control (unexercised) 
condition; EX = exercised condition. 
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Pellet implantation and sham procedures were performed under aseptic 
conditions. Rats were anaesthetized via inhaled isoflurane, and a small incision was 
made in the skin folds of the neck. Blunt dissection was used to separate the skin from the 
underlying fascia. For supplemented animals, the estrogen pellet (0.25 mg 17(3-estradiol, 
21-day time release pellet, Innovative Research of America, Sarasota, FL) and/or the 
progesterone pellet (25 mg progesterone, 21-day time release pellet, Innovative Research 
of America, Sarasota, FL) were inserted under the skin approximately 1-2 cm from the 
site of incision using forceps. For the sham procedure, blunt dissection and insertion of 
the forceps was performed similar to pellet procedure, but without a pellet insertion. The 
incision was sealed with Vetabond (3M St. Paul, MN) and skin staples (APPOSE ULC, 
USS DG, USA). Animals were allowed to recover for 7 days prior to beginning the 
exercise protocol. This recovery time also allowed the pellet implanted groups to receive 
prolonged exposure to hormones. 
The animals being exercised were exposed to 5 minute familiarization sessions, 
one and two days prior to performing the exercise protocol. The animals ran on a 
motorized rodent treadmill with an electric shock grid (Columbus Instruments, 
Columbus, OH). The exercised animals were run on a motorized rodent treadmill 
downhill at a -13.5° grade at a speed of 17 m/min. They ran for a total of 90 min using 
an intermittent protocol of 5 min running interspersed with 2 min of rest, as described 
elsewhere (79). This protocol is non-fatiguing and has been shown to elicit damage in 
the soleus and white vastus muscles in rodents (14; 80). 
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Tissue collection 
All animals were sacrificed by an overdose of sodium pentobarbital (55 mg/kg i.p.). The 
exercised animals were sacrificed 24 hours post-exercise. The control animals were 
euthanized at the same time as the exercised animals. Anesthesia was confirmed with the 
loss of withdrawal reflex from a toe web pinch. During sacrifice, the lower abdomen was 
opened and a blood sample (5 mL) was withdrawn from the descending aorta. Blood was 
allowed to clot, and centrifuged for 10 minutes at 3000 g. The serum was removed and 
stored at -20°C. The soleus and superficial (white) portion of the vastus muscle and 
uterus were removed. These muscle regions contain predominately Type I and Type lib 
fibres, respectively (81). Tissue samples were thoroughly rinsed in physiological saline 
to remove excess blood, blotted dry and trimmed of visible connective tissue and 
tendons. The fibres of the muscle were properly aligned and the muscle samples were 
mounted and coated in optimal cutting temperature (OCT) medium and quickly frozen in 
isopentane chilled to the temperature of liquid nitrogen, in preparation for 
immunohistochemical analysis. All tissue samples were immediately placed in liquid 
nitrogen, then stored at -20°C until analysis. 
Serum Estrogen Assay 
Serum estrogen levels were analyzed in duplicate using a commercially available 
radioimmunoassay (RIA) kit (Coat-a-Count TKE21, Inter Medico, Markham, ON). 
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Progesterone Level Assay 
Serum progesterone levels were analyzed in duplicate using a commercially available 
radioimmunoassay (RIA) kit (Coat-a-Count TKPG2, Inter Medico, Markham, ON). 
^•Glucuronidase Activity Assay 
(3-glucuronidase activity was measured in the muscle samples using the method of Barrett 
(82) as described by Koskinen et al. (83). Samples were assayed in triplicate at 420 nm. 
Samples were expressed as the amount of substrate (5 mM p-nitrophenyl-P-D-
glucuronide, Sigma-Aldrich) hydrolyzed per amount of protein and incubation time. To 
determine the total protein content in the samples the Lowry Protein Assay was 
performed (84). 
Lowry Protein Assay to Determine Total Protein Content 
Total protein content in muscle homogenates was measured using the Lowry Protein 
Assay (84). Each sample was assayed in triplicate at 650 nm. Measured protein values 
were corrected against a "blank" (water sample) and compared against a bovine serum 
albumin standard (Sigma-Aldrich, St. Louis, MO). 
Immunohistochemistry to Determine Inflammatory Response 
Neutrophil and macrophage cells in soleus and white vastus muscles were determined by 
sectioning the muscles onto Vactabond coated glass slides (Vector Laboratories, 
Burlington, ON). Transverse serial sections of soleus and white vastus muscles were cut 
at 10 \im using a cryostat (Leica CM3050S, Germany) at -20°C. The slides were stored at 
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-20°C until staining. Sections were immunostained for the leukocyte markers: His48 
(present primarily on neutrophils) and EDI (present primarily on macrophages). 
To quantify the cells, slides were placed under a light microscope (Leica DMLS) 
with the image projected onto a computer screen at a magnification of 400x (lOx ocular 
and 40x objective lens). Twenty random fields were selected and ten fibres from those 
fields were analyzed. This procedure was performed on two different cross sections of 
the same muscle, for a total of 400 fibres being analyzed from each sample. Cells on the 
outer edges of the cross section and those present in blood were excluded during 
quantification. Figure 8 depicts representative positive cells that were used during the 
quantification of leukocytes. 
Statistical Analysis 
All data are presented as means ± SEM. Differences between groups were measured 
using a 2 (exercise) by 3 (conditions) factorial ANOVA at a level of significance of P < 
0.05. Where significance was obtained, post-hoc multiple comparison testing was done 
using a Bonferroni test to determine where specific differences had occurred. 
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Figure 8: Representative images showing sections (10 fxm) of rat skeletal muscles 
immunostained for (A) neutrophils (His48) and (B) macrophages (EDI) (400x 
magnification). 
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Results 
Serum Estrogen Levels 
Since exercise had no effect on serum estrogen levels, animals were pooled into four 
groups according to their supplementation status: sham, progesterone-supplemented, 
estrogen-supplemented and progesterone plus estrogen-supplemented groups. As 
depicted in Table 4, estrogen administered rats had significantly higher (P < 0.05) serum 
estrogen levels relative to sham (unsupplemented) and progesterone treated rats. 
Additionally, serum estrogen levels of progesterone plus estrogen-supplemented animals 
were significantly greater (P < 0.05) than both sham animals and those that received only 
progesterone treatment. There was no significant difference (P > 0.05) between estrogen-
supplemented animals and those receiving both progesterone plus estrogen 
supplementation. 
Serum progesterone levels 
Since exercise had no effect on serum progesterone levels, animals were pooled into four 
groups: sham, progesterone-supplemented, estrogen-supplemented and progesterone plus 
estrogen-supplemented groups. As seen in Table 4, progesterone-supplemented animals 
had greater serum progesterone concentrations than sham (unsupplemented) rats (P < 
0.05). Additionally, progesterone plus estrogen-supplemented animals had significantly 
greater serum progesterone levels relative to estrogen-supplemented and sham 
(unsupplemented) rats (P > 0.05). There was no significant difference (P > 0.05) between 
progesterone only supplemented animals and those receiving both progesterone plus 
estrogen supplementation. 
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Body Weights 
All groups continued to gain weight throughout the experimental period. However, sham 
(unsupplemented) animals were significantly heavier than estrogen only treated animals 
and estrogen plus progesterone treated animals at the time of sacrifice (P < 0.05), as 
depicted in Table 4. There was no significant weight difference between progesterone 
supplemented animals and sham (unsupplemented) animals (P > 0.05) at sacrifice. These 
data are in line with previous work demonstrating that estrogen administration to estrogen 
naive animals results in reduced body weight gain and lower body mass than sham 
(unsupplemented) animals (52; 57) and progesterone only supplemented animals (93). 
Age matched animals were chosen for the present study because weight matching 
between the groups would have involved using estrogen treated animals of higher age 
than sham and progesterone only treated animals. Since the present study was interested 
in using adult female rats, the experimental design avoids differences in age and age-
related differences in hormonal status as confounding factors. 
^•Glucuronidase Activity 
To determine whether the exercise protocol resulted in lower exercised induced muscle 
damage in estrogen and/or progesterone supplemented animals relative to 
unsupplemented animals, measurements of the activity of the lysosomal acid hydrolase, 
P-glucuronidase were assessed. However, this assay detects muscle damage 72 hours 
post-exercise, as demonstrated by previous studies performed by our laboratory (57); as 
such, the present study did not display significantly differential responses in (3-
glucuronidase activity between groups 24 hours post-exercise (P > 0.05) . 
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Leukocyte Infiltration 
Leukocyte infiltration was measured by immunostaining for the neutrophil 
marker, His48, and the macrophage marker, EDI. A main effect with exercise was 
observed in neutrophils and macrophages, with control (unexercised) animals 
demonstrating significantly lower (P < 0.05) leukocyte content compared to animals 24 
hours after exercise in both muscle types. Also, a main effect with hormone 
administration was observed in neutrophils and macrophages, for both the soleus and 
white vastus muscles; the sham animals had significantly greater (P < 0.05) content than 
the estrogen treated and estrogen plus progesterone treated animals. Also, the 
progesterone only treated animals had significantly greater (P < 0.05) neutrophil and 
macrophage content than the estrogen treated and estrogen plus progesterone treated 
animals. 
Significantly increased (P < 0.05) neutrophil infiltration was observed 24 hours 
post-exercise in both the soleus and white vastus muscles relative to control (unexercised) 
animals (Figures 9 and 10). Progesterone supplemented animals displayed significantly 
decreased (P < 0.05) neutrophil infiltration following exercise compared to control 
animals, in both muscle types. Estrogen supplementation significantly attenuated (P < 
0.05) neutrophil infiltration compared to sham animals by 74 and 67% in the soleus and 
white vastus, respectively. The combination of progesterone and estrogen 
supplementation did not significantly alter the attenuating affect of estrogen in both 
muscle types. 
The number of macrophage cells detected in sections of the soleus and white 
vastus muscles are depicted in Figure 11 and 12, respectively. There was a significant 
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increase (P < 0.05) in muscle macrophage infiltration detected between control 
(unexercised) and 24 hours post-exercise sham animals, for both muscle types. Post-
exercise, macrophage infiltration was significantly reduced (P < 0.05) in progesterone 
supplemented animals compared to sham animals, in both muscle types. Additionally, 
exercised animals that received estrogen supplementation significantly attenuated 
(P < 0.05) macrophage infiltration in both the soleus and white vastus muscles. Estrogen 
and progesterone combined supplementation did not significantly alter the attenuation 
observed by estrogen alone. 
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Table 4: Animal body weights, serum estradiol and progesterone levels for various 
treatment groups. Values are pooled means + SEM.a P < 0.05 compared to sham 
(unsupplemented). b P < 0.05 compared to progesterone-supplemented.c P < 0.05 
compared to estrogen-supplemented. 
Treatment 
Sham 
Progesterone 
Estrogen 
Progesterone + 
Estrogen 
Body Weight (g) 
290 + 5 
293 ± 5 
262 ± 4ab 
263 ± 5ab 
Serum Estrodiol (pg ml"1) 
18.9 + 2.2 
16.4±1.5 
153.0 ±35.0ab 
101.2 ± 15.6ab 
Serum Progesterone (ng ml"1) 
1.07 + 0.2 
3.5±1.39a 
1.41 ±0.35 
4.67 ± 0.73ac 
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Table 5: Changes in Muscle (3-glucuronidase Activity With Downhill Running. Values 
are means + SEM.a P < 0.05 compared to progesterone-supplemented animals. b P < 
0.05 compared to estrogen-supplemented animals. 
Sham Progesterone Estrogen Progesterone + 
Estrogen 
Soleus Control 5.32 ±0.42 6.42±0.44 4.21±0.63a 3.68±0.69a 
Exercise + 24 h 5.70 + 0.54 5.09 ±1.12 4.02 + 0.64 3.84 + 0.90 
White Vastus Control 2.92 ±0.31 2.66±0.25b 4.39 ± 0.53 3.70 ±0.40 
Exercise + 24 h 3.23 ±0.45 4.20 ±0.47 3.29 ±0.27 3.33 ±0.55 
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Figure 9: Effects of estrogen and progesterone supplementation on numbers of His48+ 
neutrophils in rat soleus (red) muscle 24 h following downhill running. Values are means 
+ SEM . a P < 0.05 compared to Control (unexercised), 
treated.).c P < 0.05 compared to Progesterone treated. 
P < 0.05 compared to Sham 
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Figure 10: Effects of estrogen and progesterone supplementation on numbers of His48+ 
neutrophils in rat white vastus muscle 24 h following downhill running. Values are means 
+ SEM. 
treated.c 
a
 P < 0.05 compared to Control (unexercised). 
P < 0.05 compared to Progesterone treated. 
P < 0.05 compared to Sham 
59 
I Sham 
I Progesterone 
I Estrogen 
i i Progesterone + Estrogen 
Control 24 h 
Figure 11: Effects of estrogen and progesterone supplementation on numbers of ED1+ 
macrophages in rat soleus (red) muscle 24 h following downhill running. Values are 
means + SEM. a P < 0.05 compared to Control (unexercised). b P < 0.05 compared to 
Sham treated.c P < 0.05 compared to Progesterone treated. 
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Sham 
Progesterone 
Estrogen 
H Progesterone + Estrogen 
Control 24 h 
Figure 12: Effects of estrogen and progesterone supplementation on numbers of EDI+ 
macrophages in rat white vastus muscle 24 h following downhill running. Values are 
means + SEM.a 
Sham treated. c 
P < 0.05 compared to Control (unexercised). 
P < 0.05 compared to Progesterone treated. 
P < 0.05 compared to 
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Discussion 
We induced hormonal manipulation in the form of ovariectomized females to 
examine the specific and interaction effects of estrogen and progesterone on skeletal 
muscle in response to injury. It has been well established that estrogen reduces post-
exercise skeletal muscle damage. However, the influence of progesterone plus estrogen 
in combination on skeletal muscle damage has not been extensively studied. 
The major new findings of this study were that a) following exercise the 
percentage of leukocyte infiltration decreased significantly with estrogen 
supplementation in both muscle types, 67-69% and 63-74% in neutrophils and 
macrophages, respectfully; b) the combination of estrogen and progesterone 
supplementation did not significantly alter the attenuation observed by estrogen alone; 
c) leukocyte infiltration post-exercise in the soleus (red) and white vastus muscles were 
decreased in ovariectomized rats treated with progesterone alone relative to 
unsupplemented ovariectomized rats. 
As expected, the estrogen only supplemented animals and those receiving 
estrogen plus progesterone had significantly higher serum estradiol levels compared to 
the unsupplemented ovariectomized and progesterone only supplemented animals. These 
levels are considered to be on the upper end of the physiological range and consistent 
with 17(3-estradiol replacement values found in other laboratories and our own (52; 89). 
Reported estrogen levels range as high as 285 pg ml"' (90) to values such as 15 pg ml"1 
(91). Progesterone levels were considered to be at low physiological levels. The range 
of circulating estrogen and progesterone levels are quite large and variable. Age and 
stage of estrus cycle contribute to this variability. The rats in this study were exposed to 
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constant levels of estrogen and/or progesterone. Under physiological conditions 
concentrations are continuously fluctuating over a 3-4 day cycle. Therefore, a limitation 
of this study is that the findings might not represent leukocyte infiltration in response to 
damage that occurs when normal fluctuations occur in progesterone and estrogen levels. 
This study demonstrated that skeletal muscle in female rats benefited from 
progesterone treatment alone and in combination with estrogen following injury. The 
protective effect of progesterone was depicted by its attenuation of leukocyte 
inflammation. A novel finding was seen with the concurrent administration of estrogen 
plus progesterone; progesterone and estrogen combined supplementation did not 
significantly alter the attenuation observed by estrogen treatment alone in skeletal 
muscle. Conversely, some studies have found that the addition of progesterone may 
counteract the beneficial actions of estrogen. For example, in rat arteries following 
vascular injury Xing et al. (75) observed that the addition of progesterone and estrogen in 
combination negated the protective inflammatory effect observed by estrogen alone. The 
estrogen dosage used in this study resulted in estrogen levels consistent with our study 
(75). The progesterone dosage used was approximately 3 mg day"1, greater than our 
dosage of 1.2 mg day"1. 
In support of our findings, it has been shown that in the brain there is an 
upregulation of progesterone receptors with the combined treatment of progesterone and 
estrogen (94). Furthermore, Balaraman et al. (95) demonstrated that female rats with 
progesterone administration displayed a cardioprotective effect following myocardial 
ischemia/reperfusion (I/R) injury compared to males and ovariectomized females 
receiving progesterone supplementation. Progesterone treated ischemic females showed 
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significantly reduced muscle damage (serum CK levels), inflammation (neutrophil 
infiltration), lipid peroxidation levels (superoxide dismutase and glutathione levels), and 
apoptotic markers (DNA fragmentation) compared to vehicle treated I/R females (95). 
The progesterone dosage of approximately 0.6 mg i.p. following I/R injury, along with 
the endogenous circulating estrogen, was sufficient to elicit a response in the female rats. 
Moreover, these findings suggest that there is an interaction effect with progesterone and 
estrogen in female rats. 
In conclusion, the present study not only demonstrates that progesterone 
independently influences skeletal muscle leukocyte infiltration due to injury, but in 
combination with estrogen, progesterone does not impede the attenuating influence of 
estrogen on post-damage leukocyte infiltration. 
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Chapter Four 
Discussion & Conclusion 
It is well known that estrogen influences muscle damage and repair processes. 
The movement of leukocytes (neutrophils and macrophages) into skeletal muscle is a 
critical response following injury. Our laboratory was the first to demonstrate that 
estrogen replacement in ovariectomized female rats and male-supplemented rats resulted 
in diminished leukocyte infiltration and inflammatory response in skeletal muscle (18). 
We have also demonstrated that muscle damage in response to exercise is attenuated with 
estrogen supplementation compared to sham (unsupplemented) animals (57). We have 
begun to examine the mechanisms behind estrogen's influence on skeletal muscle 
inflammation. Our laboratory's results demonstrated that estrogen administration to 
ovariectomized female rats induces elevations in cardiac neutrophils while suppressing 
calpain activity (96). Additionally, we have been examining the relationship between 
estrogen and the muscle repair process. Recently our laboratory has found greater 
numbers of total, activated and proliferating satellite cells post-exercise in estrogen 
supplemented animals compared to the non-estrogen supplemented group. The results 
demonstrate that estrogen may influence post-damage repair of skeletal muscle through 
activation of satellite cells (57). 
The mechanism by which estrogen influences inflammation in damaged skeletal 
muscle needs to be examined further. Understanding the mechanism behind estrogen's 
effects may allow us to optimize and manipulate this process. In the first study, we 
investigated the role of estrogen receptors on muscle leukocyte infiltration following 
eccentric exercise in ovariectomized female rats with or without estrogen 
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supplementation. We blocked the estrogen receptors with ICI 182, 780 to see if this 
altered estrogen's action on these parameters. 
The study found an estrogen specific inflammatory response; with estrogen 
supplemented animals demonstrating an attenuation of leukocyte infiltration in skeletal 
muscle post-exercise compared to sham ovariectomized animals. Furthermore, treatment 
of the ovariectomized estrogen supplemented rats with the ER antagonist, ICI 182, 780 
did not alter the leukocyte inflammatory response to exercise relative to those treated with 
estrogen alone, indicating that the hormonal mechanism is not primarily receptor 
mediated. 
Further work needs to be conducted in order to understand the mechanisms 
behind estrogen's effects during inflammation. Our study was successful in ruling out the 
estrogen receptors as the primary means by which estrogen exerts its effects. Perhaps 
estrogen is acting via non-receptor mediated mechanisms, such as direct interactions with 
other membrane components, induction of HSPs, or even through an antioxidant effect. 
It has been suggested that estrogen may have a membrane stabilizing effect. 
Estrogen is a fat-soluble hormone, capable of incorporating into the lipid bilayer of the 
cell and stabilizing the membrane (58). It is thought that this interaction could alter the 
fluidity and function of the membrane. Or perhaps, estrogen may possess antioxidant 
properties, donating the hydrogen atoms from their phenolic hydroxyl group, halting the 
free radical peroxidation chain reactions (60). In this respect, exposure of skeletal muscle 
to estrogen may reduce muscle damage. Another possible mechanism for estrogen's 
effects may be through the induction of heat shock proteins. Exercise induced muscle 
damage results in an increase in intracellular denatured proteins, signaling the induction 
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of the HSP response to mediate the proper folding of denatured proteins (68). A 
relationship has been demonstrated between the induction of the HSP response and a 
decrease in injury in cardiac muscle (69). Therefore, it is speculated that estrogen may 
exert its effect through one of the non-estrogen receptor mediated mechanisms, such as 
HSP induction, antioxidant effect or a membrane stabilization effect. 
The vast majority of mammalian hormone based studies that examine 
inflammation in response to muscle injury, only examine the influence of estrogen. 
However, by only examining estrogen and not progesterone we are not gaining an 
accurate understanding of the effects of female sex hormones. Therefore, we used a more 
physiologically valid model in our second study to verify the effects of both estrogen and 
progesterone alone in combination on leukocyte inflammation post-exercise. Our main 
objective was to examine the effects that progesterone had on estrogen's ability to reduce 
exercised induced muscle damage. 
The study demonstrated that female rats benefited from progesterone and estrogen 
treatment alone, as depicted by an attenuation in inflammation following injury. A novel 
finding was seen with the concurrent administration of estrogen plus progesterone; 
progesterone and estrogen combined supplementation did not alter the attenuation 
observed by estrogen treatment alone in skeletal muscle. Therefore, progesterone and 
estrogen in combination do not influence the leukocyte inflammatory response in an 
additive or negating manner relative to estrogen supplementation alone following 
exercise. Moreover, these results support earlier estrogen only studies. We now know 
that the addition of progesterone, to make the study more physiologically relevant, would 
not change these results. 
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There has been limited work on the mechanism of progesterone's effect, but what 
is known is that there is a similar distribution of estrogen and progesterone receptors in 
most of the same cell types and tissues which may suggest that estrogen is involved in 
progesterone receptor induction (72). In the uterus, progesterone's effect is mediated by 
its receptors and estrogen increases progesterone receptor levels (73). 
The practical implications of exploring this area may be for post-menopausal 
females that could be more prone to muscle injury. These women have altered hormone 
levels when they enter menopause and hormone intervention strategies involving 
estrogen and progesterone may be of importance. 
A limited number of estrogen replacement (in the form of hormonal replacement 
therapy) studies have been conducted on postmenopausal women to assess their effects 
on skeletal muscle damage. Even the examination of pre-menopausal and post-
menopausal women's effects to skeletal muscle damage is scarce. Of the studies 
conducted, it has been found that estrogen replacement did not offer a protective effect to 
skeletal muscle from exercised induced damage (97; 98); since no significant differences 
in serum creatine kinase levels were found among the groups. The results from human 
based studies are not consistent with those of animal based studies. Perhaps this 
discrepancy is due to the variability that exists in humans or the small samples sizes for 
human based studies. 
Additionally, further knowledge of the mechanisms behind muscle inflammation 
can be optimized (eg. ER involvement and estrogen/progesterone interaction) to develop 
pharmaceutical or other intervention strategies to aid the skeletal muscle inflammation 
process. 
68 
Reference List 
J. Proske U and Morgan DL. Muscle damage from eccentric exercise: mechanism, 
mechanical signs, adaptation and clinical applications. J Physiol 537: 333-345, 
2001. 
2. McCully KK and Faulkner JA. Injury to skeletal muscle fibers of mice 
following lengthening contractions. J Appl Physiol 59: 119-126, 1985. 
3. Enoka RM. Eccentric contractions require unique activation strategies by the 
nervous system. J Appl Physiol 81: 2339-2346, 1996. 
4. Warren GL, Ingalls CP, Lowe DA and Armstrong RB. Excitation-contraction 
uncoupling: major role in contraction-induced muscle injury. Exerc Sport Sci Rev 
29: 82-87, 2001. 
5. Eston RG, Lemmey AB, McHugh P, Byrne C and Walsh SE. Effect of stride 
length on symptoms of exercise-induced muscle damage during a repeated bout of 
downhill running. ScandJMed Sci Sports 10: 199-204, 2000. 
6. Howell JN, Chleboun G and Conatser R. Muscle stiffness, strength loss, 
swelling and soreness following exercise-induced injury in humans. J Physiol 
464: 183-196, 1993. 
7. Newham DJ, Jones DA and Clarkson PM. Repeated high-force eccentric 
exercise: effects on muscle pain and damage. J Appl Physiol 63: 1381-1386, 
1987. 
8. Newham DJ, McPhail G, Mills KR and Edwards RH. Ultrastructural changes 
after concentric and eccentric contractions of human muscle. J Neurol Sci 61: 
109-122, 1983. 
9. Friden J, Sjostrom M and Ekblom B. Myofibrillar damage following intense 
eccentric exercise in man. Int J Sports Med 4: 170-176, 1983. 
10. Duan C, Delp MD, Hayes DA, Delp PD and Armstrong RB. Rat skeletal 
muscle mitochondrial [Ca2+] and injury from downhill walking. J Appl Physiol 
68: 1241-1251, 1990. 
69 
11. Belcastro AN, Shewchuk LD and Raj DA. Exercise-induced muscle injury: a 
calpain hypothesis. Mol Cell Biochem 179: 135-145, 1998. 
12. Duncan CJ and Jackson MJ. Different mechanisms mediate structural changes 
and intracellular enzyme efflux following damage to skeletal muscle. J Cell Sci 
87 (Pt 1): 183-188,1987. 
13. Bar PR and Amelink GJ. Protection against muscle damage exerted by 
oestrogen: hormonal or antioxidant action? Biochem Soc Trans 25: 50-54, 1997. 
14. Han XY, Wang W, Komulainen J, Koskinen SO, Kovanen V, Vihko V, 
Trackman PC and Takala TE. Increased mRNAs for procollagens and key 
regulating enzymes in rat skeletal muscle following downhill running. Pflugers 
Arch 437: 857-864, 1999. 
15. Clarkson PM and Tremblay I. Exercise-induced muscle damage, repair, and 
adaptation in humans. J Appl Physiol 65: 1-6, 1988. 
16. McHugh MP, Connolly DA, Eston RG and Gleim GW. Exercise-induced 
muscle damage and potential mechanisms for the repeated bout effect. Sports Med 
27: 157-170, 1999. 
17. Fielding RA, Manfredi TJ, Ding W, Fiatarone MA, Evans WJ and Cannon 
JG. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation 
in skeletal muscle. Am J Physiol 265: R166-R172, 1993. 
18. Tiidus PM and Bombardier E. Oestrogen attenuates post-exercise 
myeloperoxidase activity in skeletal muscle of male rats. Acta Physiol Scand 166: 
85-90, 1999. 
19. Tidball JG. Inflammatory cell response to acute muscle injury. Med Sci Sports 
ExerclT. 1022-1032,1995. 
20. Lowe DA, Warren GL, Ingalls CP, Boorstein DB and Armstrong RB. Muscle 
function and protein metabolism after initiation of eccentric contraction-induced 
injury. J Appl Physiol 79: 1260-1270, 1995. 
70 
21. Tiidus PM, Bombardier E, Xeni J, Bestic NM, Vandenboom R, Rudnicki MA 
and Houston ME. Elevated catalase activity in red and white muscles of MyoD 
gene-inactivated mice. Biochem Mol Biol bit 39: 1029-1035, 1996. 
22. Labrador V, Riha P, Muller S, Dumas D, Wang X and Stoltz JF. The strength 
of integrin binding between neutrophils and endothelial cells. Eur Biophys J 32: 
684-688, 2003. 
23. Quindry JC, Stone WL, King J and Broeder CE. The effects of acute exercise 
on neutrophils and plasma oxidative stress. Med Sci Sports Exerc 35: 1139-1145, 
2003. 
24. Malm C, Nyberg P, Engstrom M, Sjodin B, Lenkei R, Ekblom B and 
Lundberg I. Immunological changes in human skeletal muscle and blood after 
eccentric exercise and multiple biopsies. J Physiol 529 Pt 1: 243-262, 2000. 
25. Cannon JG and St Pierre BA. Cytokines in exertion-induced skeletal muscle 
injury. Mol Cell Biochem 179: 159-167, 1998. 
26. Butterfield TA, Best TM and Merrick MA. The dual roles of neutrophils and 
macrophages in inflammation: a critical balance between tissue damage and 
repair. JAM Train 41: 457-465, 2006. 
27. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J 
Leukoc Biol 56: 672-686, 1994. 
28. Nguyen HX and Tidball JG. Interactions between neutrophils and macrophages 
promote macrophage killing of rat muscle cells in vitro. J Physiol 547: 125-132, 
2003. 
29. Ji LL. Exercise and oxidative stress: role of the cellular antioxidant systems. 
Exerc Sport Sci Rev 23: 135-166, 1995. 
30. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol 
Regul Integr Comp Physiol 288: R345-R353, 2005. 
31. Tidball JG and Wehling-Henricks M. Macrophages promote muscle membrane 
repair and muscle fibre growth and regeneration during modified muscle loading 
in mice in vivo. J Physiol 578: 327-336, 2007. 
71 
32. Tidball JG. Inflammatory cell response to acute muscle injury. Med Sci Sports 
Exercll: 1022-1032, 1995. 
33. McLennan IS. Degenerating and regenerating skeletal muscles contain several 
subpopulations of macrophages with distinct spatial and temporal distributions. J 
Anat 188 ( Pt 1): 17-28, 1996. 
34. Merly F, Lescaudron L, Rouaud T, Crossin F and Gardahaut MF. 
Macrophages enhance muscle satellite cell proliferation and delay their 
differentiation. Muscle Nerve 22: 724-732, 1999. 
35. Keane MP and Strieter RM. The importance of balanced pro-inflammatory and 
anti-inflammatory mechanisms in diffuse lung disease. Respir Res 3: 5, 2002. 
36. Kovacs EJ and DiPietro LA. Fibrogenic cytokines and connective tissue 
production. FASEB J 8: 854-861, 1994. 
37. Nathan CF. Secretory products of macrophages. J Clin Invest 79: 319-326, 1987. 
38. Anderson JE. A role for nitric oxide in muscle repair: nitric oxide-mediated 
activation of muscle satellite cells. MolBiol Cell 11: 1859-1874, 2000. 
39. Wozniak AC, Kong J, Bock E, Pilipowicz O and Anderson JE. Signaling 
satellite-cell activation in skeletal muscle: markers, models, stretch, and potential 
alternate pathways. Muscle Nerve 31: 283-300, 2005. 
40. Anderson J and Pilipowicz O. Activation of muscle satellite cells in single-fiber 
cultures. Nitric Oxide 7: 36-41, 2002. 
41. Schultz E and Jaryszak DL. Effects of skeletal muscle regeneration on the 
proliferation potential of satellite cells. Mech Ageing Dev 30: 63-72, 1985. 
42. Sabourin LA and Rudnicki MA. The molecular regulation of myogenesis. Clin 
Genet 57: 16-25,2000. 
43. Husmann I, Soulet L, Gautron J, Martelly I and Barritault D. Growth factors 
in skeletal muscle regeneration. Cytokine Growth Factor Rev 7: 249-258, 1996. 
72 
44. Vierck J, O'Reilly B, Hossner K, Antonio J, Byrne K, Bucci L and Dodson 
M. Satellite cell regulation following myotrauma caused by resistance exercise. 
Cell Biol bit 24: 263-272, 2000. 
45. Florini JR and Magri KA. Effects of growth factors on myogenic 
differentiation. Am J Physiol 256: C701-C711, 1989. 
46. Gibson MC and Schultz E. The distribution of satellite cells and their 
relationship to specific fiber types in soleus and extensor digitorum longus 
muscles. Anat Rec 202: 329-337, 1982. 
47. Schultz E and Lipton BH. Skeletal muscle satellite cells: changes in 
proliferation potential as a function of age. Mech Ageing Dev 20: 377-383, 1982. 
48. Faulkner JA, Brooks SV and Zerba E. Muscle atrophy and weakness with 
aging: contraction-induced injury as an underlying mechanism. 7 Gerontol A Biol 
Sci MedSci 50 Spec No: 124-129, 1995. 
49. Gibson MC and Schultz E. Age-related differences in absolute numbers of 
skeletal muscle satellite cells. Muscle Nerve 6: 574-580, 1983. 
50. Kadi F, Charifi N, Denis C and Lexell J. Satellite cells and myonuclei in young 
and elderly women and men. Muscle Nerve 29: 120-127, 2004. 
51. Gustafsson JA. What pharmacologists can learn from recent advances in 
estrogen signalling. Trends Pharmacol Sci 24: 479-485, 2003. 
52. Tiidus PM, Holden D, Bombardier E, Zajchowski S, Enns D and Belcastro A. 
Estrogen effect on post-exercise skeletal muscle neutrophil infiltration and calpain 
activity. Can J Physiol Pharmacol 79: 400-406, 2001. 
53. Tiidus PM, Pushkarenko J and Houston ME. Lack of antioxidant adaptation to 
short-term aerobic training in human muscle. Am J Physiol 271: R832-R836, 
1996. 
54. St Pierre SB, Correia LA and Cannon JG. Sex differences in leukocyte 
invasion in injured murine skeletal muscle. Res Nurs Health 22: 243-250, 1999. 
73 
55. McClung JM, Davis JM and Carson JA. Ovarian hormone status and skeletal 
muscle inflammation during recovery from disuse in rats. Exp Physiol 92: 219-
232, 2007. 
56. Tiidus PM, Deller M and Liu XL. Oestrogen influence on myogenic satellite 
cells following downhill running in male rats: a preliminary study. Acta Physiol 
Scand 184: 67-72, 2005. 
57. Enns DL and Tiidus PM. Estrogen influences satellite cell activation and 
proliferation following downhill running in rats. J Appl Physiol 104: 347-353, 
2008. 
58. Wiseman H and Quinn P. The antioxidant action of synthetic oestrogens 
involves decreased membrane fluidity: relevance to their potential use as 
anticancer and cardioprotective agents compared to tamoxifen? Free Radic Res 
21:187-194, 1994. 
59. Tiidus PM. Influence of estrogen on skeletal muscle damage, inflammation, and 
repair. Exerc Sport Sci Rev 31: 40-44, 2003. 
60. Sugioka K, Shimosegawa Y and Nakano M. Estrogens as natural antioxidants 
of membrane phospholipid peroxidation. FEBS Lett 210: 37-39, 1987. 
61. Wiik A, Glenmark B, Ekman M, Esbjornsson-Liljedahl M, Johansson O, 
Bodin K, Enmark E and Jansson E. Oestrogen receptor beta is expressed in 
adult human skeletal muscle both at the mRNA and protein level. Acta Physiol 
Scand 179: 381-387, 2003. 
62. Lemoine S, Granier P, Tiffoche C, Berthon PM, Rannou-Bekono F, 
Thieulant ML, Carre F and Delamarche P. Effect of endurance training on 
oestrogen receptor alpha transcripts in rat skeletal muscle. Acta Physiol Scand 
11 A: 283-289, 2002. 
63. Britt KL and Findlay JK. Estrogen actions in the ovary revisited. J Endocrinol 
175: 269-276, 2002. 
64. Gustafsson JA, Saartok T, Dahlberg E, Snochowski M, Haggmark T and 
Eriksson E. Studies on steroid receptors in human and rabbit skeletal muscle -
clues to the understanding of the mechanism of action of anabolic steroids. Prog 
Clin Biol Res 142: 261-290, 1984. 
74 
65. Wiik A, Gustafsson T, Esbjornsson M, Johansson O, Ekman M, Sundberg 
CJ and Jansson E. Expression of oestrogen receptor alpha and beta is higher in 
skeletal muscle of highly endurance-trained than of moderately active men. Acta 
Physiol Scand 184: 105-112,2005. 
66. Lemoine S, Granier P, Tiffoche C, Berthon PM, Thieulant ML, Carre F and 
Delamarche P. Effect of endurance training on oestrogen receptor alpha 
expression in different rat skeletal muscle type. Acta Physiol Scand 175: 211-217, 
2002. 
67. Lindquist S. The heat-shock response. Annu Rev Biochem 55: 1151-1191, 1986. 
68. Ellis RJ and Hartl FU. Protein folding in the cell: competing models of 
chaperonin function. FASEB J 10: 20-26, 1996. 
69. Currie RW, Tanguay RM and Kingma JG, Jr. Heat-shock response and 
limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts. 
Circulation 87: 963-971, 1993. 
70. Paroo Z, Dipchand ES and Noble EG. Estrogen attenuates postexercise HSP70 
expression in skeletal muscle. Am J Physiol Cell Physiol 282: C245-C251, 2002. 
71. Paroo Z, Tiidus PM and Noble EG. Estrogen attenuates HSP 72 expression in 
acutely exercised male rodents. Eur J Appl Physiol Occup Physiol 80: 180-184, 
1999. 
72. Shughrue PJ, Stumpf WE and Sar M. The distribution of progesterone receptor 
in the 20-day-old fetal mouse: an autoradiographic study with [125I]progestin. 
Endocrinology 123: 2382-2389, 1988. 
73. Curtis SW, Clark J, Myers P and Korach KS. Disruption of estrogen signaling 
does not prevent progesterone action in the estrogen receptor alpha knockout 
mouse uterus. P roc Natl Acad Sci USA 96: 3646-3651, 1999. 
74. Schneider BS, Fine JP, Nadolski T and Tiidus PM. The effects of estradiol and 
progesterone on plantarflexor muscle fatigue in ovariectomized mice. Biol Res 
Nurs 5: 265-275, 2004. 
75 
75. Xing D, Miller A, Novak L, Rocha R, Chen YF and Oparil S. Estradiol and 
progestins differentially modulate leukocyte infiltration after vascular injury. 
Circulation 109: 234-241, 2004. 
76. Fielding RA, Manfredi TJ, Ding W, Fiatarone MA, Evans WJ and Cannon 
JG. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation 
in skeletal muscle. Am J Physiol 265: R166-R172, 1993. 
77. Tidball JG and Wehling-Henricks M. Macrophages promote muscle membrane 
repair and muscle fibre growth and regeneration during modified muscle loading 
in mice in vivo. J Physiol 578: 327-336, 2007. 
78. Wakeling AE, Dukes M and Bowler J. A potent specific pure antiestrogen with 
clinical potential. Cancer Res 51: 3867-3873, 1991. 
79. Komulainen J, Kytola J and Vihko V. Running-induced muscle injury and 
myocellular enzyme release in rats. J Appl Physiol 77: 2299-2304, 1994. 
80. Armstrong RB, Ogilvie RW and Schwane JA. Eccentric exercise-induced 
injury to rat skeletal muscle. J Appl Physiol 54: 80-93, 1983. 
81. Delp MD and Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers 
and citrate synthase activity of rat muscle. J Appl Physiol 80: 261-270, 1996. 
82. Barrett AJ. Lysosomal enzymes. In: Lysosomes. A Laboratory Handbook, edited 
by Dingle JT. Amsterdam: North-Holland, 1972, p. 46-126. 
83. Koskinen SO, Wang W, Ahtikoski AM, Kjaer M, Han XY, Komulainen J, 
Kovanen V and Takala TE. Acute exercise induced changes in rat skeletal 
muscle mRNAs and proteins regulating type IV collagen content. Am J Physiol 
Regul Integr Comp Physiol 280: R1292-R1300, 2001. 
84. LOWRY OH, ROSEBROUGH NJ, FARR AL and RANDALL RJ. Protein 
measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951. 
85. Tsivitse SK, McLoughlin TJ, Peterson JM, Mylona E, McGregor SJ and 
Pizza FX. Downhill running in rats: influence on neutrophils, macrophages, and 
MyoD+ cells in skeletal muscle. Eur J Appl Physiol 90: 633-638, 2003. 
76 
86. Frenette J, St Pierre M, Cote CH, Mylona E and Pizza FX. Muscle 
impairment occurs rapidly and precedes inflammatory cell accumulation after 
mechanical loading. Am J Physiol Regul Integr Comp Physiol 282: R351-R357, 
2002. 
87. Katzenellenbogen BS, Montano MM, Le Goff P, Schodin DJ, Kraus WL, 
Bhardwaj B and Fujimoto N. Antiestrogens: mechanisms and actions in target 
cells. J Steroid Biochem Mol Biol 53: 387-393, 1995. 
88. Koot RW, Amelink GJ, Blankenstein MA and Bar PR. Tamoxifen and 
oestrogen both protect the rat muscle against physiological damage. J Steroid 
Biochem Mol Biol 40: 689-695, 1991. 
89. Chen SJ, Li H, Durand J, Oparil S and Chen YF. Estrogen reduces myointimal 
proliferation after balloon injury of rat carotid artery. Circulation 93: 577-584, 
1996. 
90. McNuIty PH, Jagasia D, Whiting JM and Caulin-Glaser T. Effect of 6-wk 
estrogen withdrawal or replacement on myocardial ischemic tolerance in rats. Am 
J Physiol Heart Circ Physiol 278: H1030-H1034, 2000. 
91. Persky AM, Green PS, Stubley L, Howell CO, Zaulyanov L, Brazeau GA and 
Simpkins JW. Protective effect of estrogens against oxidative damage to heart 
and skeletal muscle in vivo and in vitro. Proc Soc Exp Biol Med 223: 59-66, 2000. 
92. Fielding RA, Manfredi TJ, Ding W, Fiatarone MA, Evans WJ and Cannon 
JG. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation 
in skeletal muscle. Am J Physiol 265: R166-R172, 1993. 
93. Heitkemper MM and Bond EF. Gastric motility in rats with varying ovarian 
hormone status. West J Nurs Res 17: 9-19, 1995. 
94. Moffatt CA, Rissman EF, Shupnik MA and Blaustein JD. Induction of 
progestin receptors by estradiol in the forebrain of estrogen receptor-alpha gene-
disrupted mice. J Neurosci 18: 9556-9563, 1998. 
95. Dhote VV and Balaraman R. Gender specific effect of progesterone on 
myocardial ischemia/reperfusion injury in rats. Life Sci 81: 188-197, 2007. 
77 
96. Tiidus PM, Zajchowski S, Enns D, Holden D, Bombardier E and Belcastro 
AN. Differential effect of oestrogen on post-exercise cardiac muscle 
myeloperoxidase and calpain activities in female rats. Acta Physiol Scand 11 A: 
131-136,2002. 
97. Dobridge JD and Hackney AC. The effects of estrogen on indices of skeletal 
muscle tissue damage after eccentric exercise in postmenopausal women. Fiziol 
Cheloveka 30: 98-102, 2004. 
98. Buckley-Bleiler R, Maughan RJ, Clarkson PM, Bleiler TL and Whiting PH. 
Serum creatine kinase activity after isometric exercise in premenopausal and 
postmenopausal women. Exp Aging Res 15: 195-198, 1989. 
78 
Appendix A 
p-Glucuronidase Enzyme Assay 
REACTION 
p-nitrophenyl-beta-D-glucuronide +H2O —• alcohol + D-glucuronide + p-nitrophenyl 
PROCEDURE 
1. Homogenize tissue (10-20 mg; optimal 15 mg) in glass pestle using a 33.33:1 
(3%) dilution using distilled water. 
-use 16.66667 times the mass of tissue, do this 2 times 
2. Add 50 jil of homogenate and water to appropriately labeled test tube 
3. Add 450 |il of Acetate buffer to tubes using repeater pipette 
4. Pre-incubate tubes in 37°C bath for 5 minutes 
5. Add 250 (J,l of substrate using repeater pipette 
6. Incubate for 16-18 hours tubes in 37°C bath 
7. Add 1.5 ml of cold glycine buffer using repeater pipette 
8. Cool in ice water for 10 minutes 
9. Centrifuge at 3500 rpm for 10 minutes (temp 4°C) 
10. Read on spectrophotometer at 420 nm. 
REAGENT PREPARATION 
1.Sodium acetate (anhydrous) (C2H302Na) (0.1N) (mw 82.03) 
0.82 g in 100 ml of H20 pH 4.2 
2.Glycine Buffer (0.1M) pH 10.8 
A) 0.375g glycine (C2H5N02, mw 75.07) + 0.2922g NaCl (mw 58.44) in 50 ml H20 
B) 0.4 g of NaOH (mw 40) in 100 ml of H20 
Mix 52.2 ml of A and 47.8 ml of B and pH to 10.8 
3) Substrate: p-nitrophenyl-beta-D-glucuronide (5mM) (sigma N-1627) (mw 315.2) 
7.88 mg in 5 ml H20 
STANDARD PREPARATION 
Standard: p-nitrophenol (10 mM liquid p-NP solution was purchased from Sigma) 
Serial Dilution, mM To make: 
0.125 Take 563 |ll of 10 mM p-NP stock and add 437 (ll dH20 
0.0625 Take 500 |il of 0.125 mM solution and add 500 jil dH20 
0.03125 Take 500 jil of 0.0625 mM solution and add 500 jo.1 dH20 
0.015625 Take 500 \il of 0.03125 mM solution and add 500 (xl dH20 
0 (distilled water) 
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Appendix B 
HIS48 Immunohistochemistry 
Used frozen sections of rat muscle cut 10 microns thick. 
1. Let slides air dry for 5 min or until warmed up to room temperature. 
2. Fix sections with 100% cold acetone for 10 min. 
3. Let slides air dry for 5-10 min. 
4. Permeablize cells in 0.5% Triton X-100 solution (in PBS) for 5 min. 
5. Wash in PBS for 3 x 5 min. 
6. Apply 0.6% H2O2 (in absolute methanol) for 10 min. 
7. Wash in PBS for 3 x 5 min. 
8. Block with 5% normal goat serum in PBS (containing 5% nonfat milk powder) for 30 
min. Tap off excess. 
9. Incubate in primary antibody: HIS48 (1/50 diluted in blocking solution) (BD 
Biosciences, Mississauga, ON) for 3 h. 
10. Wash in PBS for 3 x 5 min. 
11. Apply bottle 3: GAM-Biotin (from Dako LSAB-2 kit) for 10 min. 
12. Wash in PBS for 3 x 5 min. 
13. Apply Bottle 4: Streptavidin-HRP (from Dako LSAB-2 kit) for 10 min. 
14. Wash in PBS for 3 x 5 min. 
15. Apply Vector NovaRed stain for 3 min (or until desired intensity is achieved). 
16. Rinse in dt^O liberally from wash bottle, then wash in bath for 2 x 5 min. 
17. Counterstain using Vector Hematoxylin QS (add hematoxylin for 10-15 s and rinse 
off with running 37°C tap water for 30 s). 
18. Place a drop of permanent mounting medium on cover slip and place slide upside 
down onto cover slip so that mounting medium covers section completely. 
19. Invert slide and apply gentle pressure on cover slip to remove any air bubbles. 
Notes: 
* All kit reagents should be equilibrated to room temperature prior to procedures and 
all incubations are done at room temperature 
* Place all buffer baths on rocker for gentle agitation 
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REAGENTS: 
PBS, 0.015 M working solution (pH 7.6): 
lxPBS lOx PBS 
Na2HP04 * 7H20 (FW 268.1) 3.495 g 34.95 g 
NaH2P04 * H26 (FW 138.0) 0.27 g 2.7 g 
NaCl (FW 58.44) 9.0 g 90 g 
For lx PBS solution: Measure reagents, add approx. 950 ml dH20, pH to 7.6, and bring 
up to 1 L with dH20. Store at room temperature. 
For lOx PBS solution: 
Measure reagents, add approx. 950 ml dH20, pH to 7.6, and bring up to 1 L with dH20. 
Store at room temperature. Each day: take out 100 ml of 1 Ox stock PBS solution and add 
900 ml dH20. 
0.5% Triton X-100 solution: 
Add 5 ml of Triton X-100 to 995 ml of lx PBS. Store at room temperature. 
0.6% HiOo solution (in MeOH): 
Add 10 ml of 30% stock H202 to 490 ml absolute methanol. Store at 4°C. 
Blocking solution (5% normal goat serum in 5% nonfat milk powder/PBS): 
For 10 ml: 
Weigh out 0.5 g nonfat milk powder. 
Add 9.5 ml lx PBS. 
Add 500 |il normal goat serum. 
Store at 4°C. 
For 5 ml of a 1:50 dilution of His48 antibody: 
Take 4.90 ml blocking solution and add 100 \il primary antibody (BD Biosciences, 
Mississauga, ON). 
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Appendix C 
EDI Immunohistochemistry 
Used frozen sections of rat muscle cut 10 microns thick. 
1. Let slides air dry for 5 min or until warmed up to room temperature. 
2. Fix sections with 100% cold acetone for 10 min. 
3. Let slides air dry for 5-10 min. 
4. Permeablize cells in 0.5% Triton X-100 solution (in PBS) for 5 min. 
5. Wash in PBS for 3 x 5 min. 
6. Apply 0.6% H2O2 (in absolute methanol) for 10 min. 
7. Wash in PBS for 3 x 5 min. 
8. Block with 5% normal goat serum in PBS (containing 5% nonfat milk powder) for 30 
min. Tap off excess. 
9. Incubate in primary antibody: EDI (1/100 diluted in blocking solution) (AbD Serotec, 
Raleigh, NC) for 1 h. 
10. Wash in PBS for 3 x 5 min. 
11. Apply bottle 3: GAM-Biotin (from Dako LSAB-2 kit) for 10 min. 
12. Wash in PBS for 3 x 5 min. 
13. Apply Bottle 4: Streptavidin-HRP (from Dako LSAB-2 kit) for 10 min. 
14. Wash in PBS for 3 x 5 min. 
15. Apply Vector NovaRed stain for 4 min (or until desired intensity is achieved). 
16. Rinse in dHiO liberally from wash bottle, then wash in bath for 2 x 5 min. 
17. Counterstain using Vector Hematoxylin QS (add hematoxylin for 10-15 s and rinse 
off with running 37°C tap water for 30 s). 
18. Place a drop of permanent mounting medium on cover slip and place slide upside 
down onto cover slip so that mounting medium covers section completely. 
19. Invert slide and apply gentle pressure on cover slip to remove any air bubbles. 
Notes: 
* All kit reagents should be equilibrated to room temperature prior to procedures and 
all incubations are done at room temperature 
* Place all buffer baths on rocker for gentle agitation 
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Appendix D 
Lowry Protein Assay 
PROCEDURE: 
1. Use 12*75 mm culture tubes and do samples, standards, and blanks in triplicate. 
2. Add 50 (J.1 of standards to appropriately labelled tubes. 
3. Add 50 ill of water to tubes labelled REAGENT BLANK. 
4. Prepare a 20:1 dilution of homogenizing media (10 |il media + 190 (il water). Add 50 
(LXl of dilute media to tubes labelled SAMPLE BLANK. 
5. Prepare a 20:1 dilution of EACH tissue sample (10 |il sample + 190 |iil water). Add 50 
|iil of dilute sample to tubes labelled SAMPLE. 
6. Add 0.5 ml of alkaline copper reagent to all tubes. 
7. Mix well and let stand for 10 minutes at 25°C (room temperature). 
8. Add 2.0 ml of phenol reagent to each tube. Mix each tube individually 
IMMEDIATELY after adding phenol reagent. 
9. Incubate for 5 minutes at 55°C. 
10. Cool in tap water for 1 minute. 
11. Read on spectrophotometer at 650 nm. 
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{PRIVATE IRE AGENTS: 
1. ALKALINE COPPER REAGENT: 
0.05 g CuS04.5H20 
10.00 g Na2C03 
0.10 g POTASSIUM SODIUM TARTRATE 
2.00 g NaOH 
TO 100 ml WATER ADD THE CuS04 AND DISSOLVE COMPLETELY. ADD 
THE REMAINING REAGENTS IN ORDER. STORE AT 20°C FOR 2 WEEKS. 
2. FOLIN-CIOCALTEU PHENOL REAGENT: (Sigma-Aldrich, St. Louis. MO) 
TO 80 ml WATER ADD 5.0 ml of 2 N PHENOL REAGENT. MAKE FRESH 
DAILY. 
3. BOVINE SERUM ALBUMIN STANDARD, 1.0 mg/ml: (BSA.Sigma-Aldrich, St. 
Louis, MO) 
ADD 10 mg of BSA TO 10 ml WATER. MIX BY INVERSION. SERIAL 
DILUTE TO OBTAIN SOLUTIONS AS FOLLOWS: 
1.0 mg/ml 
0.5 mg/ml 
0.25 mg/ml 
0.125 mg/ml 
0.0 mg/ml 
CALCULATION: 
(A65o of sample - A6so of sample blank) 
(A650 of standard - A650 of reagent blank) 
Multiply by 
Concentration of Standard (mg/ml) * 20 (dilution factor) = Protein concentration, mg/ml 
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